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ABSTRACT 
 
 
 
Dembinski, Gina M. M.S., Purdue University, August 2013. Evaluation of the IrisPlex 
DNA-Based Eye Color Prediction Tool in the United States. Major Professor: Christine J. 
Picard. 
 
 
 
DNA phenotyping is a rapidly developing area of research in forensic biology.  
Externally visible characteristics (EVCs) can be determined based on genotype data, 
specifically from single nucleotide polymorphisms (SNPs).  These SNPs are chosen 
based on their association with genes related to the phenotypic expression of interest, 
with known examples in eye, hair, and skin color traits.  DNA phenotyping has forensic 
importance when unknown biological samples at a crime scene do not result in a criminal 
database hit; a phenotype profile of the sample can therefore be used to develop 
investigational leads.  IrisPlex, an eye color prediction assay, has previously shown high 
prediction rates for blue and brown eye color in a European population.  The objective of 
this work was to evaluate its utility in a North American population.  We evaluated the 
six SNPs included in the IrisPlex assay in an admixed population sample collected from a 
U.S.A. college campus.  We used a quantitative method of eye color classification based 
on (RGB) color components of digital photographs of the eye taken from each study 
volunteer and placed in one of three eye color categories: brown, intermediate, and blue.  
Objective color classification was shown to correlate with basic human visual 
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determination making it a feasible option for use in future prediction assay development.  
In the original IrisPlex study with the Dutch samples, they correct prediction rates 
achieved were 91.6% for blue eye color and 87.5% for brown eye color.  No intermediate 
eyes were tested.  Using these samples and various models, the maximum prediction 
accuracies of the IrisPlex system achieved was 93% and 33% correct brown and blue eye 
color predictions, respectively, and 11% for intermediate eye colors.  The differences in 
prediction accuracies is attributed to the genetic differences in allele frequencies within 
the sample populations tested.  Future developments should include incorporation of 
additional informative SNPs, specifically related to the intermediate eye color, and we 
recommend the use of a Bayesian approach as a prediction model as likelihood ratios can 
be determined for reporting purposes.
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CHAPTER 1. INTRODUCTION 
 
 
 
When biological material is left at a crime scene, ultimately the purpose of the 
forensic analysis of that evidence is to obtain a DNA profile.  DNA profiling is 
considered the gold standard of forensic science because it allows for reliable individual 
identification with statistical support [3].  DNA profiling is currently based on the 
exploitations of the genetic variations within each individual’s DNA, known as short 
tandem repeats (STR).  Once generated from the biological material, the STR profiles 
from crime scene samples can then be used for comparison between putative individuals.  
One method is through searching DNA databases for possible lists of suspects.  
Currently, the main database is maintained by the Federal Bureau of Investigation (FBI), 
a database called the Combined DNA Index System (CODIS).  There are also databases 
at local and state levels, but these feed into the national database.  The profiles are 
currently based on 13 core STR loci (markers) [4].  There are close to 11 million profiles 
that exist in the national database (C. Sobieralski, Indiana State Police, personal 
communication). 
There have been improvements in the sensitivity of STR testing where DNA profiles 
are now routinely obtained from minute quantities of biological material not visible to the 
naked eye [5].  However, the limitation of DNA evidence is when a DNA profile from a 
crime scene fails to match any one individual from a DNA database.  FBI CODIS 
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statistics showed that DNA profiles increased exponentially from 2001-2006, yet hits 
increased linearly which leads to an increasing discrepancy between unmatched DNA 
profiles and hits [6].  At this time, a DNA profile does not provide any informative 
characteristics of the contributor other than the sex of the individual.  Therefore, an 
unknown suspect(s) can never be identified using the current genetic markers in forensic 
DNA profiling [7].  One way to overcome this limitation is to obtain additional genetic 
information from the biological material to complement the STR profile.  One of the 
rapidly developing areas in forensic biology is the ability to predict externally visible 
characteristics (EVC) of an individual based on DNA-based genetic information, known 
as DNA phenotyping [8].  In DNA phenotyping, single nucleotide polymorphism (SNP) 
markers, as opposed to STR markers, are found associated with EVC genes, and can be 
typed for the prediction of a particular phenotype prediction purposes [7].  Human sex 
determination is an accurately predicting EVC that is currently in use with existing DNA 
profiles [7].  In 2001, Grimes et al. [6] published the first example of a phenotype 
prediction test showing that variants in the MC1R gene was indicative of the red hair 
phenotype [2].  EVCs that show the most promise for the successful development of 
forensic prediction tests in the near future are skin, hair, and eye color; they are among 
the most visible phenotypic traits [9] and have a small number of markers that account 
for a large proportion of the variation [6]. 
As a complement to conventional STR profiling, DNA phenotyping can be used as an 
investigational tool, not just for criminal casework, but also those pertaining to missing 
persons or mass disasters [8].  For example, the information from a DNA phenotype 
profile will either corroborate or negate eye witness statements [8].  This has been 
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demonstrated in a criminal investigation to aid in a Louisiana serial killer case in 2003. 
DNAPrint Genomics, a genetic testing company, had developed an ancestry phenotype 
test called DNAWitness 1.0, which included 71 informative ancestry informative markers 
(AIMs) [10].  Eyewitness testimony had suggested a Caucasian assailant, and after 
finding no leads, the task force commissioned the DNAWitness testing, where the results 
suggested the contributor was predominantly African.  A month later, the suspect, 
Derrick Todd Lee, an African-American male, was arrested and has since been convicted 
in two murders [10].  Once developed fully for forensic applications, the information 
possible from these predictions may help in developing plausible leads for investigations, 
especially in cases when they are limited. 
The full genetic determination of externally visible traits is still being explored; 
however, many studies have identified genes and SNPs of interest that contribute to 
variation in pigmentation, such as eye, hair, or skin color, which results in differences of 
the expressed traits [2, 9, 11-19].  Melanin production and distribution is especially found 
to affect the expression of these phenotypes, thus the SNPs associated with pigmentation 
gene loci can be useful for the development of prediction models. 
The objective of this work was to evaluate a previously developed DNA-based 
phenotyping assay that predicts eye color, called IrisPlex, as an informative forensic tool 
to be used within the United States.  IrisPlex includes an assay of six eye color 
informative SNPs and a statistical model for predicting iris color.  IrisPlex has been 
validated for several European populations [20, 21] in predicting blue and brown eye 
color, but still lacked evaluation with more admixed individuals, such as those in the U.S. 
population.  In this current study, adjusted and alternative prediction models were also 
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tested, and quantitative color measurement for determining iris color was also applied as 
an objective color classification method. 
 
 
 
1.1 Iris Structure 
Human eye color expression is based on genetic, developmental, molecular, and 
morphological features of the iris [1].  The stroma and anterior layer of the iris have been 
shown to be the most important structural cell layers for eye color appearance and contain 
pigment cells (see Figure 1.1) [1].  Pigment cells are called melanocytes.  Stromal 
melanocytes have the same embryological origin as dermal melanocytes, and they 
migrate through the uveal tract during development [1].  The iris pigmented epithelium 
(IPE), the posterior layer, is always pigmented regardless of eye color, except in 
individuals who exhibit albinism [1].  The stromal layer consists of loose connective 
tissue made of fibroblasts, melanocytes, and several collagen fibril proteins [1].  It has 
been shown that approximately 66% of the stromal composition is made of melanocytes, 
regardless of eye color; no statistical significance is seen in the total mean melanocyte 
number (the same cell density among different color groups) [22].  Unlike hair and skin 
where melanin (pigment) is continuously produced and secreted, melanosomes in the iris 
are retained in the iris (stroma) [1].  Three factors considered the major determining 
factors of the appearance of iris color are: pigment granules in the iris pigment epithelium 
(IPE), concentration of pigment in stromal melanocytes, and light scattering and 
absorptive properties of extracellular components [23]. 
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1.2 Pigmentation and Melanogenesis 
Melanin is a indole derivative of 3,4 di-hydroxy-phenylalanine (DOPA) and is 
formed from tyrosine in a series of oxidative steps [24].  The major known function of 
melanin is protection against UV-induced DNA damage as it absorbs and scatters the UV 
radiation [24].  Variation in the expression of human pigmentation is described by 
differences in the type of melanin, the amount of melanin synthesized in melanosomes 
(specialized vesicles) and the size, shape, and export of melanosomes to the hair, skin, 
and iris [6].  There are two types of melanin, eumelanin (EM) and pheomelanin (PM) 
which differ mainly in sulfur content [6].  Most melanin pigments present in hair, skin, 
and eyes are complex heteropolymers made up of both EM and PM building blocks, not a 
homopolymer of one or the other [25].  Eumelanin is a brown/black pigment and 
pheomelanin is a yellow/red pigment.  A study on cultured uveal melanocytes 
demonstrated a trend in the type of melanin and eye color.  Dark iris colors have a greater 
amount of EM, intermediate iris colors (i.e., green) have more PM and the lighter eye 
Figure 1.1.  Transverse view of the human iris [1].  The five structural layers of the iris 
can be seen.  Reproduced with permission from Springer Science and Business Media. 
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colors, such as blue, have very little of either pigment [23].  The formation of pupillary 
rings (brown around blue, brown around green) are not yet genetically understood [26]. 
Melanogenesis is illustrated in Figure 1.2.  The first step in melanin formation is 
oxidation of tyrosine to L-DOPA, this is known as the Raper-Mason pathway [24].  L-
DOPA activates the enzyme tyrosinase.  Mutations of tyrosinase affecting its function 
lead to forms of oculocutaneous albinism, hereditary disorders resulting in melanin 
deficiency (or absence) [24].  The pathway begins with the α-melanocyte stimulating 
hormone (α-MSH) binding to the melanocortin 1 receptor (MC1R).  Melanocortin 
receptors have seven transmembrane domains and are a group belonging to the G-protein 
coupled receptor superfamily; MC1R is expressed in melanocytes [24].  This binding of 
α-MSH leads to a G-protein dependent activation of adenylate cyclase  and increases 
cAMP levels to activate protein kinase A (PKA) [24].  PKA induces the microphthalmia 
transcription factor (MITF) [24].  The MITF regulates transcription of tyrosinase and of 
Rab27a, which is an important protein in melanosome transport [24].  Tyrosinase, once 
activated, acts on tyrosine to make dopaquinone and addition of cysteine if present [2].  
When cAMP is limited, pheomelanin formation is favored [2].  Tyrosine related protein I 
(TYRP1) is stimulated by MITF along with dopachrome tautomerase (DCT) which will 
lead to eumelanin production as long as the following required proteins Pmel17, MATP, 
P, and SLC24A5 are present, all which are important to transport and maturation of the 
melanosome structure [2]. 
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1.3 Pigmentation Genes and Informative SNPs 
Common variants associated with normal pigmentation in humans have thus far been 
identified currently by genome-wide association studies (GWAS) in six genes: MC1R, 
OCA2, SLC24A5, MATP (SLC45A2), ASIP, and TYR [9].  The MC1R gene relates to the 
MC1R receptor in the melanogenesis pathway.  The OCA2 gene encodes the P protein 
involved in melanogenesis, as well as the MATP gene.  The ASIP gene encodes the agouti 
signaling protein which interacts with the MC1R receptor and competes with binding of 
α-MSH to the MC1R receptor in melanogenesis, this can lead to higher production of 
pheomelanin [27].  It has also been shown to lead to expression of yellow coat color in 
mice, therefore it influences the expression of lighter pigmentation [27].  Specifically for 
Figure 1.2.  Illustration of melanogenesis.  Shown is the melanogenesis pathway leading 
to the production of eumelanin and/or pheomelanin. Genes boxed in blue are included in 
IrisPlex. Adapted from Tully [2]. 
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eye color, three SNPs in these pigment associated genes are shown to have significant 
reduced melanin effects in human melanocytes to further support their involvement in 
pigmentation: rs12913832 (HERC2), rs16891982 (SLC24A4), and rs1426654 (SLC24A5) 
[28].  SLC24A4 and SLC24A5 have already been discussed as being involved in melanin 
production.  The function of the HERC2 gene is unknown, and will be discussed further 
below. 
Though these phenotype informative SNPs are expected to be used in future forensic 
investigations, more research is necessary as the traits of focus indicated by these SNPs 
are highly polymorphic and complex, involving several genes and contributions from 
various gene-gene interactions [13].  Complex traits do not exhibit Mendelian 
inheritance, attributed to a single gene locus with one dominant and one recessive allele.  
Complex traits could mean that the same genotype can result in more than one 
phenotype, and conversely, more than one genotype results in the same phenotype [29].  
It is nearly impossible to find a genetic marker that shows perfect co-segregation with a 
complex trait because of incomplete penetrance (has allele but phenotype not expressed), 
phenocopy (doesn’t have allele but due to environmental factors expresses the 
phenotype), genetic heterogeneity, or polygenic inheritance (more than one type of 
variant allele is required for a certain phenotype to be expressed) [29]. 
The human iris color phenotype is under strong genetic control and highly 
polymorphic in individuals especially of European descent, which is where eye color 
variation originates [8].  The ancestral expressed eye color is brown, which agrees with 
the Out-of-Africa theory of evolution stating that the modern human population is 
descendant  from a small group of Homo sapiens from Africa that emigrated [7].  Genetic 
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adaptation, especially considering the geographic adaptation of the UV response between 
Africa and Europe, is the most probable cause of pigment variation [7].  The UV 
response is more active and advantageous for Africans and individuals who live in 
regions closer to the equator as they receive higher levels of UV sun exposure and 
therefore require higher levels of melanin production than individuals who live further 
away from the equator, such as in northern regions of Europe e.g., Scandinavia. 
The SNP rs12913832 is in the highly conserved intronic region of the HERC2 gene, 
and is located upstream from the OCA2 promoter on chromosome 15 [19].  This SNP, in 
conjunction with OCA2, has the highest association to iris color, especially in predicting 
blue eye color [19].  However, no single gene could be used to make a reliable iris color 
inference which suggests intergenic complexity for iris color determination [12].  There 
have been several studies looking to identify the SNP loci that best associate with iris 
color and therefore might be used for accurate predictions.  In 2011, Walsh et al. [8] 
developed the IrisPlex assay that incorporated the six most informative eye color SNPs 
known at the time [8, 30]. 
The most significantly associated SNP involved in eye color expression is 
rs12913832.  The functionality of the HERC2 gene is still not understood [19], though in 
one study it was found to have a very significant association (p < 1.0 x 10 -300) to blue and 
brown eye color [30] .  This SNP is found in the conserved region of intron 86 on 
chromosome 15 of the HERC2 gene [31].  It is found upstream of the oculocutaneous 
albinisim II (OCA2) gene.  It has been suggested that the HERC2 gene acts as a silencer 
sequence on the OCA2 gene promoter (see Figure 1.3) [19].  Therefore if OCA2 is 
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silenced by HERC2 (C allele), blue eye color is expressed.  The T allele of rs12913832 
(HERC2) acts as an enhancer for melanin production.[32]. 
 
 
Figure 1.3.  HERC2-OCA2 interaction.  The silencer sequence in HERC2 acts on the 
promoter region of OCA2 which will lead to blue eye color expression.  Adapted from 
Eiberg et al. [19]. 
 
Before the discovery of the HERC2 dominant association, OCA2 was shown to have 
the most SNPs associated with eye color.  It is located downstream of the HERC2 gene 
on chromosome 15.  One SNP (rs1800407) of OCA2 shown with second highest 
association to eye color (p = 1.7 x 10-28) by Liu et al. [30] which is located within exon 13 
of the OCA2 gene.  There are many other SNPs linked to the OCA2 gene region that have 
been shown to have high heritability association on eye color, however the OCA2 
association to eye color is severely reduced when adjusted with the effect of rs12913832 
[30]. 
The HERC2-OCA2 region on chromosome 15 has shown highest heritable association 
with pigmentation expression, but as eye color is a complex polymorphic trait, many 
genes have additive effects to these SNPs to improve upon iris color determination.  
Another SNP is rs1393350, which is located within an intronic region of the tyrosinase 
11 
 
(TYR) gene on chromosome 11 [33].  Tyrosinase as mentioned, is a protein involved in 
melanin production.  The SNP rs12203592 is found in intron 4 of the interferon 
regulatory factor 4 (IRF4) gene on chromosome 6.  Its polymorphism has additive effects 
related to blue eye color, though it does not seem to be directly involved in the 
pigmentation pathway [34].  SNP rs12896399 is located within an intronic region of the 
SLC24A4 gene on chromosome 14.  The gene is in the same family as SLC45A5 which 
was found to be the human ortholog of the zebrafish golden gene, which influences 
expression of lighter pigmentation such as blonde hair and blue eyes [6].  SNP 
rs16891982 is a non-synonymous variant within exon 5 of the SLC45A2 gene, also 
known as the membrane associated transporter protein (MATP) gene, on chromosome 5.  
This gene is thought to be involved in the intracellular processing and trafficking of 
melanosomal proteins, e.g. tyrosinase [2]. 
As these eye color informative SNPs are being discovered, there have been several 
studies in developing assays that range in differing combination of SNP markers for eye 
color prediction [6, 8, 35, 36].  One of the first highly successful eye color prediction 
assays designed is IrisPlex.  Developed in the Netherlands and based on a Dutch 
population, the IrisPlex assay detects six SNPs: rs12913832, rs1800407, rs1393350, 
rs12203592, rs12896399, and rs16891982 associated with the following genes, 
respectively: HERC2, OCA2, SLC45A2, SLC24A4, IRF4, and TYR [8].  These markers 
were found at the time to be the six highest associated SNPs to eye color expression [8].  
Eye color predictions were made in three eye color categories: brown, blue, or 
intermediate.  In the original published work [8], the predictive ability is high for blue 
and brown eye color (91.6% blue and 87.5% brown) using a prediction model based from 
12 
 
multinomial logistic regression which has parameters derived from minor allele 
frequencies [8].  This particular model, though accurate at predicting blue and brown eye 
color, used a homogenous population in which no intermediate eye colored individuals 
were tested. 
The objective of this work was to test the IrisPlex model (under the described 
parameters, [8]) in an admixed North American population.  When it was determined that 
the predictive power of the model did not give similar accuracy as the original study of 
Dutch individuals, we developed additional models for the use of eye color prediction 
and also incorporated a method for objective quantification of color based on the color 
components obtained from digital photographs. 
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CHAPTER 2. METHODOLOGY 
 
 
 
2.1 Sample Collection 
Buccal swabs were collected from 200 anonymous volunteers (Indiana University 
IRB Approval Protocol #1111007371).  At the time of buccal swab collection, a digital 
photograph was also taken of each volunteer’s right eye (with care for volunteers to 
remove any corrective lenses).  A Canon PowerShot digital camera (Canon Inc., Tokyo, 
Japan) was used with macro mode, ISO80, and flash settings.  A light box was built for 
photo collection to ensure equal distance and lighting conditions for all photos. 
 
 
 
2.2 DNA Extraction and Quantitation 
DNA was extracted by a modified organic extraction.  Briefly, swabs were incubated 
in 1.5 mL tubes at 65 °C for a minimum of 8 hrs in 500 μL lysis buffer (Invitrogen, 
Carlsbad, CA) with 50 μL proteinase K (Qiagen, Hilden, Germany).  Following lysis, the 
swabs were spun dry into tubes with the use of DNA IQTM spin baskets (Promega 
Corporation, Madison, WI) and discarded.  Then, 500 μL phenol (Thermo Fisher 
Scientific Inc., Waltham, MA) was added and centrifuged at 13,000 rpm for 1 minute.  
The aqueous layer was removed to a new tube and 500 μL phenol: chloroform: isoamyl 
alcohol (25:24:1) (Thermo Fisher Scientific Inc.) was added and centrifuged at 13,000 
rpm for 1 minute.  The aqueous layer was removed and placed into a new tube to which 
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500 μL of cold 95% ethanol (Thermo Fisher Scientific Inc.) and 25 μL of cold 0.2M 
NaCl (Thermo Fisher Scientific Inc.) was added.  The tubes centrifuged at 4 °C at 13,000 
rpm for 15 minutes.  The supernatant was discarded and the pellet was washed with 500 
μL of cold 70% ethanol (Thermo Fisher Scientific Inc.) followed by centrifugation at 4 
°C at 13,000 rpm for 5 minutes.  The supernatant was removed and the sample was 
allowed to air dry.  The sample was re-suspended in 50 μL of TE buffer (Thermo Fisher 
Scientific Inc.) and stored at -20 °C until further use.  DNA quantitation was performed 
according to the manufacturer’s specifications using the Quantifiler® Human DNA 
Quantification kit (Applied Biosystems Inc.) on a 7300 Real Time PCR System (Applied 
Biosystems Inc.). 
 
 
 
2.3 SNP Amplification and Genotyping 
SNP amplification was performed via single base extension (SBE).  SBE utilizes 
fluorescently labeled dideoxynucleotides (ddNTPs) to extend the primer by one base, 
which is the SNP of interest (Figure 2.1).  This SNP is what is detected during capillary 
electrophoresis and the output is shown as discretely spaced, peaks which color indicates 
which base variant is at the targeted site of the DNA.  Two purification steps are required 
in between the PCR reactions to inactivate unincorporated primers, dNTPs and ddNTPs. 
The same six SNPs were amplified using the same primer sequences described in 
Walsh et al. [8] where the only difference was in primer concentrations (Table 2.1).  
However, a single multiplex reaction of all six SNPs was never successfully amplified.   
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Instead, two multiplex reactions, one of four IrisPlex SNP primers (HERC2, SLC45A2, 
TYR, IRF4) and one of the remaining two IrisPlex SNP primers (SLC24A4 and OCA2) 
were amplified.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For each multiplex reaction, 1 ng of DNA was amplified in a 12uL reaction with 6uL 
of AmpliTaq Gold 360 Master Mix (Applied Biosystems) including 0.5 uL GC Enhancer, 
and a final concentration of each primer of 5.0 μM.  PCR was performed using the same 
parameters as in Walsh et al [8] on a Mastercycler Pro thermal cycler (Eppendorf, 
Hamburg, Germany). 
The PCR products were purified using USB ExoSAP-IT® (Affymetrix, Santa Clara, 
CA).  The purified PCR products were pooled for a multiplex single base extension 
(SBE) reaction, using the same SBE primers designed by Walsh et al [8].  The SBE 
reaction used 1 μL of total pooled PCR product (0.5 μL of each previously purified 
Figure 2.1.  Outline of single base extension (SBE).  Initial PCR product with primer 
sequence is then extended by base variant (target SNP) with ddNTP.  Adapted from 
SNaPshot Multiplex kit manual (Applied Biosystems Inc.). 
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product) and 2 μL of SnaPshot reaction mix in a reaction volume of 5 μL using the 
SNaPshot® Multiplex kit (Applied Biosystems).  PCR was performed on a Mastercycler 
Pro (Eppendorf) following the same SBE conditions as Walsh et al. [8].  SBE products 
were then purified using shrimp alkaline phosphatase (SAP, Takara, Kyoto, Japan). 
 
Table 2.1.  Modified IrisPlex SNP primer concentrations.  Primer concentrations were the 
only differing property from the primers designed for use in the original IrisPlex study 
[8].  All other primer properties can been found in Walsh et al. [8]. 
 
 
SNP 
Primer 
concentration 
(μM) 
Extension primer 
concentration 
(μM) 
rs12913832 2.5 1.0 
rs1800407 2.5 1.0 
rs12896399 2.5 1.0 
rs16891982 2.5 1.0 
rs1393350 2.5 1.5 
rs12203592 2.5 1.0 
 
Capillary electrophoresis was performed where 1 uL of purified SNaPshot products 
was analyzedon an ABI 3500 Genetic Analyzer (Applied Biosystems) following standard 
protocol of the SNaPshot® Multiplex kit.  Data analysis was performed using 
GeneMarker v2.20 software (SoftGenetics, State College, PA).  For sensitivity, a 
threshold of 200 rfu was set for peak intensities, and a minimum heterozygote peak 
height ratio (PHR) of 0.40 was used for genotyping, however, for IRF4 and SLC45A2, a 
PHR of 0.20 was used for genotyping due to overall low peak imbalance. 
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2.4 Iris Color Determination and Measurement 
An objective color classification method was applied in addition to basic human 
visualization for classifying the eye color of each sample into the same three categories: 
brown, blue, or intermediate. 
Eye color was determined both subjectively and objectively.  The first subjective 
manner was basic human visual identification, in which every digital photo was evaluated 
by 5 individuals to classify eye color as brown, intermediate, or blue.  Intermediate color 
was defined as any color that was not brown or blue.  The consensus rating of the 
individual examinations was used as the visual determined color. 
 
 
 
2.4.1 Color Components 
There are several generic color space models that can describe color quantitatively, 
with the intent of measuring similarly to human perception while standardizing color 
between instrumentation used to obtain the color of a given sample: RGB, HSV, 
CIEXYZ, and CIELAB.  Measuring digital color for iris color in terms of the hue and 
saturation color space has been described [14] as well as by red, blue, green (RGB) 
components [16], and by the Commission Internationale de L’Eclairage L*a*b* 
(CIELAB) color space [10, 37].  All color component values can be converted between 
each color model and therefore a color can be described within each color space.  The 
CIEXYZ color space can be considered as just xy coordinates and plotted on a two 
dimensional axis to show color chromaticity (no luminosity considered).  CIELAB 
components are thought to be perceptually uniform to that of human vision [37].  L* 
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describes the brightness dimension, a* describes the green/red dimension, and b* 
describes the blue/yellow dimension [37].  There are trends within these quantitative 
color spaces for the three eye color categories of focus here (blue, brown, intermediate), 
for example, for CIELAB colors, blue irides tend to have a high L* value, and negative 
a* and b* values; green have a high L*, a negative a*, and a b* value around zero, and 
brown irides tend to have a low L* and positive a* and b* [37].  In terms of RGB 
components, darker irises, e.g. brown, have lower RGB values than blue and intermediate 
colors.  In any of the above models, the color is a condensed value, meaning it is 
measured homogenously as a single color, therefore not capturing the complex color 
pattern that may be present, e.g. green or blue iris with a brown peripupillary ring (Figure 
2.2) [10, 37].  The color spaces applied in this study are RGB and xy coordinates to 
highlight the objective differences between the brown, intermediate, and blue eye color 
categories used for sample color classification from digital photographs. 
 
 
 
 
 
 
 
 
 
Figure 2.2.  Iris digital photo sample.  Example of an iris with a peripupillary ring. 
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2.4.2 Objective Color Classification 
A second, quantitative eye color determination was made using a numerical value 
known as the iris melanin index (IMI) [10].  This method involves determining the red, 
green, and blue (RGB) color components of the iris from each digital photo.  The iris was 
digitally extracted to determine the RGB components and luminosity value using Adobe 
Photoshop® Elements 10 (Adobe Systems Inc., San Jose, CA).  A ratio of these 
components as determined by the histogram function measures the color as a single 
numerical value, the iris melanin index (IMI) (see Figure 2.3) [10]. 
 
 
 
 
 
Figure 2.3.  The IMI formula.  Using a ratio of the average RGB color components and 
the luminosity (brightness) values as collected from the histogram function from the 
extracted iris digital photo calculates the IMI as a single value. 
 
In this work, the RGB components were converted to xy color coordinates using the 
OpenRGB software program (Logicol, Trieste, Italy), with F7 fluorescent illuminant and 
10° observation angle used in the conversion factors, allowing for two point comparison 
and graphical representations of each color category.  CIELAB color components were 
also determined through conversion.  The xy coordinates were separated statistically by 
discriminant analysis (DA) using XLSTAT 2010 (Addinsoft, Paris, France) within 
Microsoft Excel (Microsoft, Redmond, WA).  To determine that our sample population 
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was representative of the larger U.S. population, a chi-square test was done to determine 
any statistically significant deviations in population eye color frequency when compared 
to a larger U.S. sample population (State of Indiana). 
 
 
 
2.5 Statistical Phenotype Prediction Models 
Phenotype inferences, such as eye color, are determined from a statistical model.  
Models are used to produce information on the basis of valid input information; this is the 
inference process [38].  Traditional statistical models require large sample sizes, 
experimental and control samples that are distinctly different enough in terms of the 
phenotype of interest to convey significant probability power [38].  The goal of any 
model-building technique is to find the best fitting yet biologically reasonable model to 
describe the relationship between an outcome (dependent variable) and set of predictors 
(independent variables) [39]. 
 
 
 
2.5.1 Multinomial Logistic Regression Model 
Logistic regression modelling evolved from the binary based maximum likelihood 
method of estimation [40].  A logistic regression model is distinguished from a linear 
regression model in that the dependent variable is binary [39].  Multinomial models apply 
to scenarios with more than two variables assume that the categories are not ordered and 
are independent of each other [40].  The regression model gives a set of coefficients for 
each independent variable as it relates to the predictor category.  The coefficients 
represent the rate of change of a function of the dependent variable per unit of change in 
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the independent variable [39].  Multivariate statistical models, such as logistic regression, 
examines overall dependency structure between genotypes, phenotype, and 
environmental variables [38].  Model validation is important when the fitted model is 
used to predict outcome of future subjects, to assess the goodness-of-fit of the developed 
model [39]. 
Eye color prediction was done using the multinomial logistic regression model as 
used by Walsh et al. [8].  In the three category model there are two logit functions, i.e. 
two sets of coefficients per independent variable (SNP), in this case the two functions 
correspond to blue vs. brown eye color and intermediate vs. brown eye color.  The 
difference between the two gives the third logit (blue vs. brown).  This model uses 
categorical classification of subjects (eye color) based on a set of predictor variables 
(population minor allele frequencies), and calculated probabilities of each individual for 
each color category: brown, intermediate, or blue [30].  The color category with the 
highest probability is the predicted color.  The three logit functions used are as those as 
established by Liu et al. [30] 
The α and β values in the logit functions are the logistic regression intercepts and 
coefficients, respectively.  The x values are the minor allele frequencies of each SNP.  
The original model was built on data from a Dutch population that included 3804 
individuals [30] and was tested using a second sample set of 40 individuals [8].  Given 
the poor results using the model with the same parameters, minor allele frequencies were 
calculated from 100 random samples (training set) and an adjusted multinomial 
regression model was developed and tested with the remaining 100 samples (verification 
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set) using MATLAB® 2012a (The MathWorks Inc., Natick, MA).  Table 2.2 shows the 
regression coefficients of both the IrisPlex and our adjusted population. 
 
 
 
2.5.2 Bayesian Network Model 
An alternative prediction model was developed based on Bayesian network (BN) 
analysis, based on minor allele frequencies as described by Pośpiech et al. [41] using the 
Hugin Lite 7.6 software program (Hugin Expert A/S, Aalborg, Denmark) (Figure 2.4).  A 
BN gives a graphical representation of relationships between observed data and allow 
inference of an individual phenotype (e.g. eye color) based on known genotypes of an 
individual in the range of analyzed multiple SNP loci [41]. 
 
Table 2.2.  The regression parameters for the multinomial logistic regression of the 
original IrisPlex model and our adjusted frequency model.  A) The alpha intercept values.  
B) The beta coefficients for each SNP. 
 
A) 
 
 
B) 
 
 
 
 
Intercept IrisPlex [21] Adjusted 
α1 3.94 12.51 
α2 0.65 5.45 
SNP IrisPlex [21] Adjusted Minor 
Allele 
 β1 β2 β1 β2  
rs12913832 -4.81 -1.79 -13.08 -7.29 T 
rs1800407 1.40 0.87 0.54 1.89 T 
rs12896399 -0.58 -0.03 -0.27 0.91 G 
rs16891982 -1.30 -0.50 -8.43 -2.54 C 
rs1393350 0.47 0.27 0.99 -0.18 T 
rs12203592 0.70 0.73 2.31 0.64 A 
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Each node represents an uncertain variable and arrows between nodes represent links 
among the different variables [42].  The output is a conditional probability that represents 
the likelihood based on prior information [42].  They can accommodate complex 
structure of gene environment interactions with phenotypes defined by multiple variables 
(e.g. SNPs) [43]. 
The BN model gives a probability for each eye color category based on a priori odds 
of each eye color frequency.  Two a priori odds were tested: equal odd for all three color 
categories, as well as odds based on the known eye color distribution determined from 
the Indiana Bureau of Motor Vehicles database.  In addition to probabilities, likelihood 
ratios are also able to be calculated from the BN analysis model [41]. 
 
 
 
 
 
 
 
 
Figure 2.4.  Outline of the Bayesian network nodal relationship. 
 
2.5.3 Linear Discriminant Analysis 
Linear discriminant analysis, or just discriminant analysis (DA), is a multivariate 
statistic technique used to visualize group differences.  There are two sources of 
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variation, within source and between source [44].  Discriminant analysis constructs a set 
of axes to separate data into groups by maximizing between group variance and 
minimizing within group variance [45].  This is a supervised technique, meaning 
knowledge of group membership (e.g. eye color category) for each sample before 
analysis is required [45].  Classification of an unknown sample to a group also requires 
quantitative measurement of pattern similarity, in this case, RGB color components [45].  
One option with DA is to conduct a cross validation, which produces a confusion matrix 
showing the number of true positives, true negatives, false positives, and false negatives 
of the samples analyzed and overall classification rate.  This matrix is calculated by the 
leave-one-out cross validation method, where a sample is temporarily removed from the 
data set, the classifier adjusts for the remaining samples, and then used to predict the 
group classification of the removed sample [45].  The DA function in XLSTAT 
(Addinsoft) also calculates the receiver characteristic operative curve (ROC).  An ROC 
curve is a graphical plot with the false positive rate on the x axis and true positive rate on 
the y axis or, the inverse specificity vs. the sensitivity, respectively [40].  The six SNPs 
used in the IrisPlex assay were initially evaluated by Liu et al. [30] where area under the 
receiver characteristic operative curve (AUC) was used to evaluate the overall prediction 
model performance.  To compare model performance to that of the original IrisPlex 
model (e.g. ability to classify correctly), the area (AUC), sensitivity, specificity, positive 
predictive value (PPV) and negative predictive value (NPV) were determined for our 
multinomial regression and Bayesian prediction models. 
In evaluating ROC curves an AUC value of 0.5 indicates a lack of prediction ability 
and an AUC close to 1 indicates near perfect prediction accuracy.  One important note for 
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evaluating an AUC value, it reflects both true positive values (e.g. correctly predicting 
blue for blue samples) and true negative values (e.g. correctly predicting non-blue for 
non-blue samples).  Sensitivity is the true positive rate, the number of true positives out 
of the total number of positives (total number accounts for false negatives) and specificity 
is the true negative rate, the number of true negatives out of the total number of negatives 
(total number accounts for false positives).  An ideal model will give a high rate of both 
specificity and sensitivity i.e. will be accurate in predicting the true positives and 
negatives while minimizing false positives and negatives.  The PPV is the number of true 
positives out of the total number of true and false positive predictions, and the NPV is the 
number of true negatives out of the total number of true and false negative predictions. 
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CHAPTER 3. IRISPLEX EVALUATION: RESULTS AND DISCUSSION 
 
 
 
3.1 Eye Color Determination 
The digital photo’s iris color was subjectively and objectively determined for all 200 
samples.  An IMI scale was determined after digital analysis and set with highest 
agreement to the visual determinations (Table 3.1).  Values were classified as brown if 
they fell in the range 1.25-1.65, intermediate in the range of 1.66-2.32, and blue in the 
range of 2.33-3.20.  There were 22 (out of the 200 samples, Appendix A) which did not 
identify in the same color category between the objective IMI classification and 
subjective human visual determination.  All mistaken classifications were between 
intermediate and either brown or blue. 
To determine if the 200 samples were a representative sample of the Indiana 
population, data from the Indiana Bureau of Motor Vehicles (D. Rosebrough, Indiana 
BMV, personal communication) was used as a comparison to a larger sample population.  
There was no significant difference between the frequency distributions of our collected 
sample (N=200) and that collected by the BMV (N=7,115,106, Table 3.2), although there 
were a higher number of observed blue-eyed individuals in the collected samples (χ2 test, 
df=2, p > 0.10). 
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Table 3.1.  Percentage (%) of samples determined for each eye color category.  The IMI 
values calculated for each sample and the IMI ranges based on least number of 
misclassifications when compared with the visual determinations. 
 
Eye Color Visually determined (%) IMI Value IMI determined (%) 
Brown 34.0 1.25-1.65 36.5 
Intermediate 26.0 1.66-2.32 22.0 
Blue 40.0 2.33-3.20 41.5 
 
Important to note, eye color is self-reported for driving records, therefore some 
subjective discrepancy might be present.  Visual determinations cannot be disregarded 
however as they are the basis for eye witness testimonies and the practical manner of 
classification for forensic investigations; therefore, it is essential that objective eye color 
classification correlates with visual determinations.  The data illustrates that there is no 
statistical difference between the visual and quantitative eye color measurements and 
therefore the quantitative measurement (IMI) was used in further analyses. 
Quantitative color classification has led to more accurate predictions in model 
development.  One recent study used hue and saturation values in a GWAS study for 
quantifying eye color and as actual quantitation is a more systematic, objective approach 
compared to categorical classification, additional candidate eye color SNPs were 
discovered as a result [14]. 
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Table 3.2.  Eye color distribution (%) among sample population and larger scale United 
States sample population and statistical significance (χ2) between them. 
 
 Collected 
Samples (%) 
State of 
Indiana (%) 
χ2 values 
(df=2) 
Brown 34 43 1.88 
Blue 40 34  1.06 
Intermediate 26 23 0.39 
Sample Size (N) 200 7,115,106 p > 0.10 
 
Additional statistical analysis of the quantitative color components was done to 
determine if the quantitative measurements exhibit sufficient discrimination between 
color categories.  Sample color components were converted to xy color coordinates and 
demonstrates statistical separation by DA (Figure 3.1).  The ellipses shown for each color 
category in Figure 3.1 show the 95% confidence interval of a sample belonging to that 
particular group.  There is overlap seen between the ellipses only between the blue or 
brown and intermediate groups, with most occurring between brown and intermediate; 
there is no overlap of the brown and blue groups.  This is expected as most conflicting 
predictions were between either brown or blue and intermediate for the visual 
determinations. 
 
 
 
3.2 Multinomial Logistic Regression Analysis 
The six IrisPlex SNP genotypes for all individuals were determined (Appendix A) 
and used as the basis for the prediction models.  The prediction model used by Walsh et 
al. [8] calculates probabilities in each of the three color categories based on multinomial 
logistic regression using previously published formulas [30]. 
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Figure 3.1.  DA scatterplot of xy color coordinates.  Separation of each eye color 
category with 100% of the discrimination captured by the first two canonical variates.  
The x color coordinate contributes to CV1 and the y color coordinate contributes to CV2. 
 
Two different parameter sets were used for prediction evaluation: the Walsh et al. 
parameters [8] and an adjusted set based on our sample allele frequency data.  Two cut-
off probability thresholds were chosen as discussed by Walsh et al. [8] in evaluating 
accuracy of prediction, 0.5 and 0.7.  The IMI classifications, not the visual 
determinations, were used as the true eye color for each sample. 
In the Dutch study, Walsh et al. had reasonable prediction accuracies 91.6% and 56% 
for blue and brown eye colors, respectively, at the 0.7 threshold; and 91.6% and 87.5% 
for blue and brown eye colors, respectively, at the 0.5 threshold [8].  It is imperative to 
note that their sample set did not contain any individuals with an intermediate eye color. 
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Using the Walsh et al. frequencies [8], the predicted eye color rates were 5% and 52% 
for blue and brown eye colors, respectively, at the 0.7 threshold and 8% and 93% for blue 
and brown eye colors, respectively, at the 0.5 threshold (Table 3.3).  The intermediate 
color at both thresholds did not yield any true positive predictions.  Using the adjusted 
parameters (based on our training set), the predicted eye colors of the verification set (N 
= 100) were 33% and 48% for blue and brown eye colors at the 0.7 threshold, 
respectively, and 28% and 3% for blue and brown eye color at the 0.5 threshold, 
respectively.  For the intermediate color the rate of prediction was 4% at the 0.7 threshold 
and 11% at the 0.5 threshold (Table 3.3).  See Appendix B for the prediction probabilities 
for all samples. 
 
Table 3.3.  The correct prediction rates (%) by color category of all 200 samples 
evaluated for each prediction model.  Only the verification set (N=100) was evaluated 
against the adjusted regression parameters; all 200 samples were evaluated using the 
Bayesian network correct predictions with either set of a priori odds. 
 
Parameters Threshold Brown (%) Intermediate (%) Blue (%) 
MLR: IrisPlex  0.5 93 0 8 
 0.7 52 0 5 
MLR: Adjusted 0.5 48 11 33 
 0.7 3 4 28 
Bayesian: Equal odds 0.5 40 20 57 
 0.7 27 20 52 
Bayesian: Adjusted 0.5 51 23 76 
 0.7 32 2 57 
Equal odds = 0.33 each eye color category, adjusted odds= 0.33 brown, 0.44 blue, 0.17 intermediate 
 
The number of correct predictions decreased for the brown eye color and increased 
for blue and intermediate using the adjusted parameters.  The adjusted parameters did not 
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measure more accurate predictions than those of Walsh et al., however, there were fewer 
number of incorrect predictions and an increase in inconclusive predictions in which the 
probabilities in either color category did not measure above the 0.5 threshold (Figure 
3.2). 
Receiver operating characteristics (ROC) were used to evaluate model performance, 
including the area under the ROC (AUC) which is a value that compares the specificity 
and sensitivity in a model’s prediction ability.  The AUC was determined for our samples 
using the IrisPlex and adjusted parameters (Table 3.4).  Our samples evaluated with the 
IrisPlex parameters show an AUC of 0.78 for blue, 0.70 for intermediate, and 0.82 for 
brown.  They were improved when our samples were evaluated with the adjusted 
frequency parameters with AUC of 0.87 for blue, 0.78 for intermediate, and 0.83 for 
brown.  The positive predictive value (PPV) was more accurate with the adjusted 
frequency parameters with 80.5% for blue, 50% for intermediate, and 71% for brown 
(Table 3.5). 
 
Table 3.4.  AUC values of each prediction model.  AUC reflects model performance 
(ability to make accurate predictions).  Higher AUC value indicates better model 
performance.  Bold indicates the most accurate model. 
 
Prediction Model Blue Intermediate Brown 
Liu et al. [30] 0.91 0.73 0.93 
IrisPlex parameters [8] 0.79 0.70 0.82 
Adjusted parameters 0.87 0.78 0.83 
Bayesian: Equal Odds 0.90 0.82 0.86 
Bayesian: Adjusted 0.90 0.78 0.86 
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The adjusted frequency model showed more accurate negative predictive values than 
positive, and the AUC is relatively high because it considers both the true negative and 
true positive predictions.  This is also demonstrated in the measure of sensitivity and 
specificity of the model (Table 3.5).  With this model, the sensitivity is more accurate 
than the specificity.  The specificity is overestimated as the true negative rate was higher 
than the true positive rate.  True negative predictions are still important for exclusionary 
purposes in forensic investigations but true positive predictions for inferring an unknown 
individual’s phenotype are what the goal is, and with this model, positive predictions are 
not yet sufficient for acceptably accurate inferences. 
 
 
Figure 3.2.  The frequency of overall correct, incorrect, and inconclusive eye color 
predictions using the MLR model.  a) Predictions under IrisPlex parameters at the 0.5 
threshold, b) predictions under adjusted parameters at the 0.5 threshold, c) predictions 
under IrisPlex parameters at the 0.7 threshold, and d) predictions under adjusted 
parameters at the 0.7 threshold. 
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3.3 Bayesian Network Analysis 
Statistical analysis was performed using a Bayesian network prediction model as 
described by Pośpiech et al. [41].  The predictions were evaluated with two a priori 
probability scenarios.  One scenario adjusted the prior probabilities to the eye color 
frequencies of our training set, and the other scenario assumed no previous knowledge of 
population frequencies thus equal odds for each color.  Table 3.5 shows the positive 
prediction rates for each eye color category and Figure 3.3 shows a summary of the 
overall number of predictions for both prior probability sets.  See Appendix C for 
prediction probabilities for all samples of each a priori set 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.  The frequency of overall correct, incorrect, and inconclusive eye color 
predictions using the BN model.  a) Predictions under equal odds at the 0.5 threshold, b) 
predictions under adjusted frequency odds at the 0.5 threshold, c) predictions under equal 
odds at the 0.7 threshold, and d) predictions under adjusted frequency odds at the 0.7 
threshold. 
 
34 
 
The AUC for the Bayesian model was also determined for its prediction accuracy 
(Table 3.4).  The AUC with both a priori probabilities was 0.86 for brown eye color, and 
0.90 for blue eye color.  For the intermediate color, the AUC for a priori equal odds 
(equal probability) was 0.82, whereas with adjusted frequencies, it was slightly lower at 
0.78 (Table 3.4).  The positive predictive value was 82.5 for blue, 70.0 for brown, and 
46.2 for intermediate (Table 3.5). 
As previously mentioned, an advantage of a Bayesian model is the ability to calculate 
likelihood ratios.  This is a ratio between the tested outcomes and prior odds.  These 
ratios ranged between 0 and 498 (Appendix D).  Likelihood ratios are used in forensic 
interpretations based on competing hypotheses and are suitable for reporting phenotype 
inference on genotypes.  Likelihood ratios are comparisons between two probabilities of 
two possible scenarios, for example, that an individual has blue eyes, or has brown eyes.  
If the ratio (LR) between the two scenario probabilities is greater than 1, it generally 
indicates that one scenario is more likely than the other.  This is calculated in a similar 
manner as likelihood ratios for paternity testing in which nationally recognized standards 
have been developed for evaluating the meaning of an LR obtained in such cases [46].  
This could easily apply to DNA phenotyping cases. 
 
 
 
3.4 Genetic Variation within the U.S. Population 
The original IrisPlex study involved a collection of samples from a Dutch population [8].  
Geographic and ancestral differences of subpopulations affect allele frequency 
distributions within the human population.  This is especially important in forensic 
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testing, as it is an aim to design assays with loci that have little difference between 
populations so the testing can apply on a global platform.  Table 3.6 shows the allele 
frequencies of each of the SNPs used in IrisPlex assay in the 200 collected samples 
herein, the 40 samples used in the original IrisPlex study, and also includes larger scale 
allele frequency distributions of the target population from the allele frequency database 
(ALFRED). 
 
Table 3.5.  Prediction model performance test characteristics (%) of both regression and 
Bayesian parameter sets after analysis of our 200 samples.  These values were the same 
for both prior odd sets for the Bayesian model. 
PPV=positive prediction value (correctly predicted positives)                                                                               
NPV= negative prediction value (correctly predicted negatives) 
 
ALFRED compiles gene frequency data on human populations; at this point in time 
there is data on 719 populations in the database [33].  The target population used here is 
the European American population which consists of samples from across the United 
States of individuals with European descent.  It should be noted that the allele frequency 
Model Test Characteristics Blue Intermediate Brown 
IrisPlex Sensitivity 65.9 0 85.3 
Frequencies Specificity 75.0 98.8 56.4 
(MLR) PPV 67.4 0 71 
 NPV 73.7 100 75.3 
Adjusted Sensitivity 85.7 91.6 85.3 
Frequencies Specificity 75.0 41.2 56.4 
(MLR) PPV 80.5 50 71 
 NPV 81.4 88.4 75.3 
Bayesian Sensitivity 75 35.3 53.9 
Network Specificity 87.5 91.6 85.3 
(BN) PPV 82.5 46.2 70 
 NPV 81.7 87.4 74.3 
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distributions of the rs12913832 SNP, which is the highest associated eye color locus, 
vary greatly even within the same subpopulation (the United States, Table 3.6). 
This high variation within the United States population is further demonstrated by the 
differences between the reported eye color distributions among individual states (Table 
3.7).  These distributions were determined from licensed driver databases (BMV 
databases, personal communications) and are percentages of eye colors reported in as 
many as 8 color categories and were combined into one of the three color categories 
evaluated here (Table 3.7). 
 
Table 3.6.  SNP nucleotide position and allele frequency comparison.  Frequencies shown 
are ALFRED population data, the 200 collected samples in this study, and the 40 Dutch 
samples collected in the original IrisPlex study.   
 
SNP position/ 
alleles 
European American 
 (ALFRED) 
Collected Samples 
(N=200) 
IrisPlex Samples  
 (N=40) 
rs12913832       
C 0.79 0.49 0.69 
T 0.21 0.51 0.31 
rs1800407       
C 0.92 0.93 0.96 
T 0.08 0.07 0.04 
rs12896399       
G 0.43 0.61 0.6 
T 0.57 0.39 0.4 
rs1393350       
C 0.77 0.71 0.9 
T 0.23 0.29 0.1 
rs16891982       
G 0.96 0.64 0.71 
C 0.04 0.36 0.29 
rs12203592       
G 0.84 0.91 0.93 
A 0.16 0.09 0.07 
ALFRED = ALlele FREquency Database [33] 
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Furthermore, the genotype data (Appendices A and F) demonstrated, in several cases, 
confusion between either brown or blue phenotypes with intermediate phenotype for 
identical genotypes.  There were two SNP genotype profile groups that exhibited all three 
eye color phenotypes: HERC2 (C/T), OCA2 (C/C), SLC45A2 (G/G), SLC24A4 (G/G), 
TYR (C/C), IRF4 (G/G), and HERC2 (C/T), OCA2 (C/C), SLC45A2 (G/T), SLC24A4 
(G/G), TYR (C/T), IRF4 (G/G).  Knowledge of the admixed nature of the United States 
populations is further supported by the observation of increased heterozygosity and 
therefore should be considered an appropriate model population to test for validation of 
forensic assays that have only been tested on more homogeneous subpopulations. 
 
Table 3.7.  Eye color distribution among 11 states.  These distributions show the high 
degree of variation within the U.S. population (approximate percentages (%), personal 
communications, BMV databases). 
 
State Blue Intermediate Brown 
Indiana 34 23 43 
Kentucky 34 25 39 
Washington 33 23 44 
New York 21 16 63 
N. Dakota 41 28 31 
Georgia 21 16 52 
Illinois 28 21 51 
Colorado 30 25 45 
Idaho 38 27 35 
N. Carolina 28 23 49 
Wisconsin 33 21 36 
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3.5 Evaluation of Samples with Conflicting Eye Classification 
As previously stated, there were 22 collected samples where the quantitative eye 
color measurements disagreed with the visually determined classifications (Appendix E 
for photos, Table 3.8).  There are several possible reasons for the disagreement between 
visual and objective color classification of these samples.  One, the presence of a brown 
peripupillary ring can be seen in many of the 22 samples (Appendix E).  As the iris color 
was measured homogeneously from the digital photo, this could contribute to some 
differences.  Also, if there was an iris pattern present, no instruction was given to the 5 
subjective examiners as to how to consider it in their rating.  In some cases, the sample 
could have been rated intermediate because it was not seen as homogeneous brown or 
blue, even if there was only very little of another color present within the iris.  
Furthermore, the IMI values of some the samples fall within 0.05 or less of the scale cut-
off between categories (e.g., sample 279, IMI =1.70).  As the IMI scale was user-set, 
adjusting it in either direction would categorize some samples into a different color 
category.  However, as previously stated, these scale values were set where there was 
least disagreement between visual and objective classifications, and as color is not a 
discrete variable (i.e. many shades possible for any one color), the choosing a discrete 
value cut-off may not be ideal. 
The predictions of those 22 samples were compared (Table 3.9) to evaluate any 
differences in the prediction accuracy.  The quantitative values were more accurate at the 
0.5 threshold.  There were 4 and 2 more correct predictions for the MLR models, IrisPlex 
and adjusted frequency parameters, respectively.  For the BN models at the 0.5 threshold, 
0 and 2 more correct predictions, equal odds and adjusted frequencies, respectively.  The 
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visual determinations were slightly more accurate at the 0.7 threshold.  For the MLR 
models, 1 and 0 more correct predictions, IrisPlex and adjusted parameters, respectively; 
and 1 and 1 more correct predictions for the BN model with equal and adjusted odds, 
respectively.  The majority of samples had the same eye color prediction regardless of 
being evaluated by its visual or quantitative classification and were determined to have 
no change on the prediction outcome (Table 3.9). 
 
Table 3.8.  The 22 samples with conflicting visual and objective color classifications.  
Visual determinations indicates the ratings from the subjective examiners (5 total).  IMI 
indicates the IMI value and color.  Br = brown, I = intermediate, Bl = blue. 
 
Sample Visual Determinations IMI 
124 4I , 1 Br 1.65 = Br 
168 4I , 1 Bl 2.37 = Bl 
170 5 Bl 2.26 = I 
219 3 I , 2 Br 1.60 = Br 
256 5 Bl 2.31 = I 
273 4 I , 1 Br 1.58 = Br 
279 3 Br , 2 I 1.70 = I 
313 4 I , 1 Br 1.61 = Br 
319 4 Br , 1 I 1.74 = Br 
321 3 Br , 2 I 1.82 = I 
348 4 I , 1 Bl 2.37 = Bl 
367 5 I 1.60 = Br 
419 4 I , 1 Bl 2.78 = Bl 
421 3 I , 2 Bl 2.48 = Bl 
487 5 Br 1.72 = I 
652 4 I , 1 Bl 2.53 = Bl 
653 4 Bl , 1 I 2.26 = I 
726 3 I , 2 Br 1.50 = Br 
847 4 I , 1 Bl 2.49 = Bl 
853 4 I , 1 Br 1.62 = Br 
916 3 I , 2 Br 2.61 = Bl 
947 3 I , 2 Bl 2.71 = Bl 
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Table 3.9.  Comparison of the number of correct predictions of the 22 samples that 
differed in visual and quantitative eye color classification.  Visual indicates the number of 
samples where visual determination resulted in a correct prediction over the IMI 
classification.  IMI indicates the number of samples where the IMI classification results 
in a correct prediction over the visual determination.  No change indicates the number of 
samples where the difference in eye color classification did not result in a change in 
prediction. 
 
Model Threshold Visual IMI No change 
IrisPlex MLR 0.5 5 9 8 
IrisPlex MLR 0.7 3 2 17 
Adjusted MLR 0.5 4 6 12 
Adjusted MLR 0.7 2 2 18 
Equal BN 0.5 4 4 14 
Equal BN 0.7 4 3 15 
Adjusted BN 0.5 5 7 10 
Adjusted BN 0.7 4 3 15 
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CHAPTER 4. CONCLUSIONS AND FUTURE CONSIDERATIONS 
 
 
 
Eye color variation is a highly polygenic trait confirmed by GWAS studies in 
individuals of European descent [14] and the SNPs identified in the IrisPlex assay have 
proven to be useful for eye color predictions in European populations [8, 20, 30, 47].  
However, the IrisPlex assay is shown to be only moderately predictive of eye color in a 
representative U.S. population due to the presumed population admixture compared to 
European population. 
Our sample set had more inconclusive results as compared to the IrisPlex samples.  
This is likely due to the presence of intermediate samples.  As previously mentioned, the 
rs12913832 SNP at the HERC2 locus alone should explain most of the differences in 
phenotype expression between blue and brown eye color[19, 31].  At this SNP, in a 
homozygous allele state, TT is almost exclusively exhibited in brown eye phenotypes and 
CC exclusively in blue eye phenotypes.  Most of our individuals (92%) were 
heterozygous (C/T) at the HERC2 SNP.  Additional data support this hypothesis for the 
failure of prediction rates.  For example, an additional study analyzed 60 samples of 
individuals with European-Asian background and the results showed that with higher 
levels of admixture, the predictions were less accurate [48].  Also, in evaluating IrisPlex 
across Europe, which included 3840 individuals from seven other European countries, 
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and with adjustments in the regression model parameters, blue-associated alleles were 
seen at some of the SNPs in brown-eyed Europeans [20]. 
In the developmental validation study of IrisPlex, subsets from the Human Genome 
Diversity Cell Line Panel (HGDP-CEPH), a large DNA database comprised of many 
populations, were used to show prediction accuracy applied to several populations [21], 
however, the eye color phenotypes were not available for genotyped samples.  Therefore, 
even if a sample was determined to be 90% or greater for a certain eye color category, it 
may be a false positive as the actual phenotype is unknown.  Our study looked at samples 
with known phenotypes, which offers strong empirical support that predictions are not 
always accurate given a high probability in any one color category. 
Overall AUC measurements indicate the BN model of prediction performs better than 
the MLR model.  Assessing the specificity and sensitivity, although the sensitivity is 
decreased, specificity is increased, so true negative predictions are more accurate.  Also, 
likelihood ratios can be calculated from these Bayesian probabilities using the prior odds 
as described by Pośpiech [41].  Recently, Ruiz et al. reported success in using a modified 
online Bayesian classifier application, Snipper, to give such likelihood-based eye color 
predictions based on SNP allelic frequencies [35].  Still, as with the regression model, 
positive prediction inferences were not shown to be at an acceptable level for forensic 
application with a North American population, especially for the intermediate color 
category. 
Objective color quantitation is comparably better to visual color determination which 
may be more effective in classification of eye color.  One caveat of IMI is that the 
method depends on the specific sample set analyzed as the average luminosity and color 
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scale of all samples are used in deriving the single numerical value.  Also, accounting for 
iris patterns could be further considered, especially the presence of a peripupillary ring.  
A study by Larsson et al. in 2011 describes SNP markers for identifying such patterns 
relating to variations in normal neuronal pattern development [49].  Incorporating these 
iris pattern SNPs may help reduce conflicting classifications.  If using such a 
classification scheme, it may be possible to establish a reference database of group-
specific SNP profiles associated with each eye color category with a large enough sample 
population.  Using color components could also be further explored, possibly relating the 
SNP genotype with predicted color components instead of a discrete color category.  
Though considered in some studies without much success [41], further breakdown of 
color category discrimination of the intermediate colors should be explored (e.g., green 
and hazel instead of intermediate). 
In order for the IrisPlex assay to be useful as a forensic tool in a North American 
population, additional SNPs must be developed and evaluated.  Recently, three additional 
SNPs associated with the intermediate color especially were discovered and may be 
informative [14].  Eye color prediction is not the only forensically useful phenotype.  
Combining SNPs into one assay for inferring hair, skin, and eye color simultaneously 
would be ideal in developing a phenotypic profile of multiple traits based on DNA 
profiles.  Recently Walsh et al. published a combined hair and eye color assay called 
HIrisPlex [50], however, its utility in a North American population should also be 
determined. 
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REMEDY PROVIDED HEREIN.  
9. Should any provision of this Agreement be held by a court of competent jurisdiction to be 
illegal, invalid, or unenforceable, that provision shall be deemed amended to achieve as 
nearly as possible the same economic effect as the original provision, and the legality, 
validity and enforceability of the remaining provisions of this Agreement shall not be 
affected or impaired thereby.  
10. The failure of either party to enforce any term or condition of this Agreement shall not 
constitute a waiver of either party's right to enforce each and every term and condition of 
this Agreement. No breach under this agreement shall be deemed waived or excused by 
either party unless such waiver or consent is in writing signed by the party granting such 
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Agreement shall not operate or be construed as a waiver of or consent to any other or 
subsequent breach by such other party.  
11. This Agreement may not be assigned (including by operation of law or otherwise) by 
you without WILEY's prior written consent.  
12. Any fee required for this permission shall be non-refundable after thirty (30) days from 
receipt 
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17. This Agreement shall be governed by and construed in accordance with the laws of the 
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action, suit or proceeding arising out of or relating to these Terms and Conditions or the 
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and submits to the personal jurisdiction of such court, waives any objection to venue in such 
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properly cited and other license terms are observed. A small number of Wiley Open Access 
journals have retained the Creative Commons Attribution Non Commercial License (CC 
BY-NC), which permits use, distribution and reproduction in any medium, provided the 
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CC BY, the CC BY-NC and the Attribution-NoDerivatives (CC BY-NC-ND). The CC BY-
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websites in accordance with the terms of the applicable Creative Commons license 
referenced on the article. At the time of deposit, Wiley Open Access articles include all 
changes made during peer review, copyediting, and publishing. Repositories and websites 
that host the article are responsible for incorporating any publisher-supplied amendments or 
retractions issued subsequently. 
Wiley Open Access articles are also available without charge on Wiley's publishing 
platform, Wiley Online Library or any successor sites. 
Conditions applicable to all Wiley Open Access articles: 
• The authors' moral rights must not be compromised. These rights include the right of 
"paternity" (also known as "attribution" - the right for the author to be identified as 
such) and "integrity" (the right for the author not to have the work altered in such a 
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obligation of the user to ensure that any reuse complies with the copyright policies 
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• If article content is copied, downloaded or otherwise reused for research and other 
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journal, article title, volume, issue, page numbers, DOI and the link to the definitive 
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translation."  
Conditions applicable to non-commercial licenses (CC BY-NC and CC BY-NC-
ND) 
For non-commercial and non-promotional purposes individual non-commercial 
users may access, download, copy, display and redistribute to colleagues Wiley 
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translated, and text- and data-mined subject to the conditions above. 
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redistribution, sale or licensing;  
o Copying, downloading or posting by a site or service that incorporates 
advertising with such content;  
o The inclusion or incorporation of article content in other works or services 
(other than normal quotations with an appropriate citation) that is then 
available for sale or licensing, for a fee (for example, a compilation produced 
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o Use for the purposes of monetary reward by means of sale, resale, license, 
loan, transfer or other form of commercial exploitation such as marketing 
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corporatesales@wiley.com  
The modification or adaptation for any purpose of an article referencing the 
CC BY-NC-ND License requires consent which can be requested from 
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Appendix A. SNP Genotype Profiles and Eye Color Classification 
The shaded cells are the 22 samples that disagreed between visual and IMI color classification.  The 
boxed samples are the 100 random samples used for the model building. 
Sample HE OCA2 SLC24A4 SLC45A2 TYR IR Visual 
Color 
IMI IMI 
Color 
719 CT CC GG GC CC GG Br 1.25 Br 
264 CT CC GG GG CC GG Br 1.26 Br 
983 CT CC GT GG CT GG Br 1.26 Br 
194 CT CC GT GG TT GG Br 1.27 Br 
283 CT CC GG GC CC GG Br 1.28 Br 
639 CT CC GT GC CT GG Br 1.28 Br 
185 CT CC GG GG CT GG Br 1.30 Br 
193 CT CT TT GG CT GG Br 1.30 Br 
281 CT CC GG GG CT GG Br 1.30 Br 
571 CT CC GT GG CC GG Br 1.32 Br 
720 CT CC GT GG CC GG Br 1.32 Br 
930 CT CC GT GG CC GG Br 1.32 Br 
516 CT CC GT GG CT GG Br 1.33 Br 
202 CT CT GT CC CC GG Br 1.36 Br 
296 TT CC GG GC CC GG Br 1.37 Br 
271 CT CC GT GG CT GG Br 1.38 Br 
812 CT CC GG GC CC GG Br 1.38 Br 
785 CT CC GG GG CC GG Br 1.39 Br 
965 CC CC TT GG CT GG Br 1.39 Br 
125 CT CC GG GC CT GG Br 1.40 Br 
578 TT CC GG GG CC GG Br 1.40 Br 
957 TT CC GT GC CC GG Br 1.40 Br 
161 TT CC GG CC CC GG Br 1.41 Br 
163 CT CC GG GG CT GG Br 1.41 Br 
519 CT CC TT GG CC GG Br 1.41 Br 
756 CT CC GG GG CC GG Br 1.41 Br 
529 CT CC GG GG CT GG Br 1.42 Br 
143 CT CT GT GG CT GG Br 1.43 Br 
584 CT CC GG GG CC GG Br 1.43 Br 
742 CT CC GT GG CT GG Br 1.43 Br 
269 CT CC GT GG CT GG Br 1.44 Br 
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372 CT CC GT GG CT GG Br 1.45 Br 
528 CT CC GT GG CT GG Br 1.45 Br 
634 CT CC GG GG TT GG Br 1.45 Br 
751 CT CC GG GG CC GG Br 1.46 Br 
791 CT CC GT GG CC GG Br 1.46 Br 
286 CT CC GG GC CC GG Br 1.47 Br 
300 CT CC GG GC CC GG Br 1.47 Br 
328 CT CC GT GG CT GG Br 1.47 Br 
378 CT CC GT GC CT GG Br 1.47 Br 
120 CT CC GG GG CT GG Br 1.48 Br 
217 CT CC GT GG CT GG Br 1.48 Br 
265 CT CC GG GG CC GG Br 1.48 Br 
741 CT CC GG GG CT GG Br 1.48 Br 
692 CT CC GT GG CC GG Br 1.49 Br 
752 CT CC GG GC CC GG Br 1.49 Br 
181 CT CT GG GC CC GG Br 1.50 Br 
726 CT CC GT GG CC GA I 1.50 Br 
232 CT CC GT GG CT GG Br 1.51 Br 
451 CT CC GT GC CC GG Br 1.51 Br 
753 TT CC GG CC CC GG Br 1.53 Br 
825 TT CC GG GG CC GG Br 1.54 Br 
948 CT CC GG GG CT GG Br 1.54 Br 
374 CT CC GT GG CT GA Br 1.55 Br 
695 CT CC GT GG CC GG Br 1.55 Br 
657 CT CT GT GG CT GG Br 1.56 Br 
298 TT CC GG GC CC GA Br 1.57 Br 
531 CT CT GG GC CC GG Br 1.57 Br 
273 CT CC GT GG CC GG I 1.58 Br 
975 CT CC GT GG CC GA Br 1.58 Br 
219 CT CC GT GG TT GG I 1.60 Br 
367 CT CC GG GG CC GG I 1.60 Br 
492 CT CT GT GG CT GG Br 1.60 Br 
932 CT CC TT GG CC GG Br 1.60 Br 
313 CT CC TT GG CT GG I 1.61 Br 
916 CT CC GG GG CC GA I 1.61 Br 
853 CT CC GG GG CT GG I 1.62 Br 
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873 CT CC GT GG CC GG Br 1.62 Br 
176 CT CC GG GC CC GG Br 1.63 Br 
396 CT CC GG GC CC GG Br 1.63 Br 
845 CT CC GT GC CT GA Br 1.64 Br 
124 CT CC GT GG CT GG I 1.65 Br 
231 CT CC GT GG CC GG I 1.67 I 
200 CT CC TT GG CT GG I 1.68 I 
233 CT CC GG GG CC GG I 1.68 I 
412 CT CC GT GG CC GG I 1.68 I 
943 CT CC GT GG CC GG I 1.69 I 
279 CT CC GT GG TT GG Br 1.70 I 
856 CT CC GG GG TT GG I 1.71 I 
487 TT CC GG CC CC GG Br 1.72 I 
672 TT CT GG GG CT GG I 1.72 I 
700 CT CC GT GG CT GG I 1.72 I 
197 CT CC GT GG CT GG I 1.74 I 
319 CT CC GG GG CT GG Br 1.74 I 
121 CT CC GG GG CC GG I 1.76 I 
852 CT CT GT GC CT GA I 1.77 I 
765 CT CC GG GG CC GG I 1.79 I 
869 CT CT GT GG CC GG I 1.81 I 
321 CT CC GT GG CC GG Br 1.82 I 
368 CT CC GG GG CC GG I 1.85 I 
862 CT CT GG GG CC GA I 1.85 I 
354 CT CT GT GG CC GG I 1.87 I 
186 CT CT GT GG CT GG I 1.89 I 
259 CT CC GT GG CT GG I 1.91 I 
537 CT CC GT GG TT GG I 1.91 I 
135 CT CC GT GG CT GG I 1.95 I 
254 CT CC GT GG CC GA I 1.96 I 
658 CT CT GG GG CT GG I 1.96 I 
538 CT CC GG GG TT GG I 2.00 I 
388 CT CT GT GG CT GG I 2.01 I 
839 CT CT GT GG CT GG I 2.06 I 
823 CT CC GT GG CC GA I 2.09 I 
297 CT CC GG GG CT GA I 2.10 I 
512 CT CT GG GG CC GG I 2.10 I 
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182 CC CC GT GC CC GG I 2.12 I 
991 CT CC GT GG TT GG I 2.18 I 
645 CT CC GT GC CC GG I 2.19 I 
536 CT CC GT GG TT GG I 2.23 I 
758 CT CC GT GG CC GG I 2.23 I 
735 CT CC GT GG CT GA I 2.24 I 
170 CT CC TT GG CT GG Bl 2.26 I 
653 CC CC GG GG CC GG Bl 2.26 I 
196 CT CC TT GG CC GG I 2.28 I 
763 CT CC GG GG CC GG I 2.30 I 
256 CT CC TT GG CC GG Bl 2.31 I 
518 CT CC GT GG CC GG I 2.31 I 
327 CT CC GG GG CT GG Bl 2.33 Bl 
369 CT CC GT GG CT GG Bl 2.33 Bl 
362 CT CC GG GG CC GG Bl 2.36 Bl 
968 CC CC GG GG CC GG Bl 2.36 Bl 
168 CT CC TT GG CT GG I 2.37 Bl 
348 CT CC GG GG CT GG I 2.37 Bl 
917 CT CC GT GG CC GG Bl 2.39 Bl 
678 CT CT TT GG CT GA Bl 2.41 Bl 
306 CT CC GT GG CC GA Bl 2.42 Bl 
951 CT CC TT GG CT GG Bl 2.43 Bl 
187 CT CC GG GG CC GG Bl 2.46 Bl 
586 CT CC GT GG CT GG Bl 2.46 Bl 
421 CT CC GT GG TT GG I 2.48 Bl 
724 CT CC GT GG CT GG Bl 2.48 Bl 
893 CT CC GT GG CT GG Bl 2.48 Bl 
133 CT CC TT GG CC GA Bl 2.49 Bl 
847 CT CC GT GG CT GG I 2.49 Br 
123 CT CC GT GG TT GG Bl 2.51 Bl 
270 CT CC GT GG CT GA Bl 2.51 Bl 
149 CT CC GT GG TT GG Bl 2.52 Bl 
275 CT CC GG GG TT GG Bl 2.52 Bl 
569 CT CC GT GG TT GG Bl 2.52 Bl 
746 CT CC GG GG TT GA Bl 2.52 Bl 
239 CT CC GT GG CT GG Bl 2.53 Bl 
652 CT CC GG GG CC GA I 2.53 Bl 
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723 CC CT GG GG CT AA Bl 2.53 Bl 
157 CT CC GT GG CC GA Bl 2.54 Bl 
574 CT CT GG GG CC GA Bl 2.55 Bl 
879 CT CC GT GG CC GG Bl 2.55 Bl 
351 CT CC GG GG CT GA Bl 2.58 Bl 
579 CT CC GT GG TT GG Bl 2.58 Bl 
749 CT CC TT GG CT GA Bl 2.59 Bl 
122 CT CC GT GG CC GG Bl 2.61 Bl 
145 CT CC GT GG CT GA Bl 2.61 Bl 
377 CT CC TT GG CC GG Bl 2.61 Bl 
857 CT CC GT GG CC GG Bl 2.61 Bl 
160 CT CC GT GG CT GG Bl 2.62 Bl 
234 CT CT GT GG CT GG Bl 2.62 Bl 
364 CT CC GT GG TT GA Bl 2.62 Bl 
867 CT CC GT GG TT GG Bl 2.63 Bl 
539 CT CC GT GG CT GG Bl 2.64 Bl 
768 CT CT GG GG CT GA Bl 2.64 Bl 
827 CT CC GT GG CT GG Bl 2.64 Bl 
268 CT CC GT GG CT GA Bl 2.65 Bl 
305 CT CC GT GG CC GA Bl 2.66 Bl 
673 CT CT GG GG TT GG Bl 2.66 Bl 
278 CT CT TT GG CT GG Bl 2.67 Bl 
987 CT CC GT GG CC GG Bl 2.68 Bl 
453 CT CC GT GG CT GG Bl 2.69 Bl 
698 CT CC GG GG CC GG Bl 2.69 Bl 
612 CT CC GT GG CT GA Bl 2.70 Bl 
625 CT CC GT GG CC GG Bl 2.70 Bl 
834 CT CC GT GG TT GG Bl 2.71 Bl 
947 CT CC GT GG TT GG I 2.71 Bl 
276 CT CC GT GG CT GG Bl 2.73 Bl 
457 CT CC GT GG CC GG Bl 2.73 Bl 
318 CT CC GT GG CC GG Bl 2.74 Bl 
826 CC CT GT GG TT GA Bl 2.75 Bl 
128 CC CC GG GG CT GG Bl 2.76 Bl 
260 CT CC GG GG CT GG Bl 2.77 Bl 
419 CT CC GT GG CC GG I 2.78   Bl 
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986 CT CC TT GG CC GG Bl 2.78 Bl 
165 CT CC GG GG CT GG Bl 2.79 Bl 
137 CT CC GT GG TT GG Bl 2.80 Bl 
172 CT CC GT GG CT GG Bl 2.82 Bl 
134 CT CC GT GG TT GG Bl 2.83 Bl 
147 CT CC TT GG CT GG Bl 2.84 Bl 
285 CT CC GT GG CT GG Bl 2.85 Bl 
458 CT CC TT GG CT GG Bl 2.85 Bl 
769 CT CC TT GG CC GG Bl 2.90 Bl 
927 CT CC GG GG CC GG Bl 2.91 Bl 
945 CT CC GT GG CT GA Bl 2.92 Bl 
148 CT CC TT GG CT GA Bl 2.95 Bl 
169 CT CT TT GG CT GG Bl 2.96 Bl 
936 CT CC GG GG TT GG Bl 2.97 Bl 
184 CT CC GT GG TT GG Bl 2.99 Bl 
851 CT CC GT GG TT GG Bl 2.99 Bl 
152 CT CC GT GG CT GG Bl 3.00 Bl 
251 CT CC GT GG CT GA Bl 3.02 Bl 
796 CT CC TT GG CC GA Bl 3.05 Bl 
132 CT CC GT GG TT GG Bl 3.06 Bl 
498 CT CC TT GG CT GA Bl 3.10 Bl 
250 CT CC GG GG CT GG Bl 3.11 Bl 
728 CT CC GT GG TT GG Bl 3.17 Bl 
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Appendix B. MLR Prediction Probabilities 
  
    IrisPlex Predictions Adjusted Predictions 
Sample IMI IMI Color Blue Int Brown Blue Int Brown 
719 1.25 Br 0.024 0.083 0.892 0.000 0.130 0.870 
264 1.26 Br 0.094 0.148 0.758 0.143 0.295 0.562 
983 1.26 Br 0.207 0.161 0.632 0.467 0.120 0.413 
194 1.27 Br 0.277 0.179 0.543 0.719 0.073 0.208 
283 1.28 Br 0.024 0.083 0.892 0.000 0.130 0.870 
639 1.28 Br 0.060 0.102 0.838 0.000 0.076 0.924 
193 1.30 Br 0.503 0.211 0.286 0.579 0.205 0.217 
185 1.30 Br 0.134 0.175 0.691 0.323 0.261 0.415 
281 1.30 Br 0.134 0.175 0.691 0.323 0.261 0.415 
571 1.32 Br 0.150 0.140 0.711 0.229 0.150 0.621 
930 1.32 Br 0.150 0.140 0.711 0.229 0.150 0.621 
720 1.32 Br 0.150 0.140 0.711 0.229 0.150 0.621 
516 1.33 Br 0.207 0.161 0.632 0.467 0.120 0.413 
202 1.36 Br 0.027 0.111 0.861 0.000 0.121 0.879 
296 1.37 Br 0.000 0.013 0.987 0.000 0.174 0.826 
271 1.38 Br 0.207 0.161 0.632 0.467 0.120 0.413 
812 1.38 Br 0.024 0.083 0.892 0.000 0.130 0.870 
965 1.39 Br 0.962 0.025 0.013 1.000 0.000 0.000 
785 1.39 Br 0.094 0.148 0.758 0.143 0.295 0.562 
957 1.40 Br 0.000 0.013 0.987 0.000 0.089 0.911 
125 1.40 Br 0.036 0.104 0.860 0.000 0.152 0.848 
578 1.40 Br 0.001 0.026 0.973 0.000 0.426 0.574 
163 1.41 Br 0.134 0.175 0.691 0.323 0.261 0.415 
519 1.41 Br 0.229 0.128 0.643 0.325 0.068 0.607 
756 1.41 Br 0.094 0.148 0.758 0.143 0.295 0.562 
161 1.41 Br 0.000 0.006 0.994 0.000 0.056 0.944 
529 1.42 Br 0.134 0.175 0.691 0.323 0.261 0.415 
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742 1.43 Br 0.207 0.161 0.632 0.467 0.120 0.413 
143 1.43 Br 0.375 0.264 0.361 0.376 0.419 0.205 
584 1.43 Br 0.094 0.148 0.758 0.143 0.295 0.562 
269 1.44 Br 0.207 0.161 0.632 0.467 0.120 0.413 
634 1.45 Br 0.185 0.201 0.614 0.575 0.183 0.242 
528 1.45 Br 0.207 0.161 0.632 0.467 0.120 0.413 
372 1.45 Br 0.207 0.161 0.632 0.467 0.120 0.413 
751 1.46 Br 0.094 0.148 0.758 0.143 0.295 0.562 
791 1.46 Br 0.150 0.140 0.711 0.229 0.150 0.621 
328 1.47 Br 0.207 0.161 0.632 0.467 0.120 0.413 
286 1.47 Br 0.024 0.083 0.892 0.000 0.130 0.870 
300 1.47 Br 0.024 0.083 0.892 0.000 0.130 0.870 
378 1.47 Br 0.060 0.102 0.838 0.000 0.076 0.924 
265 1.48 Br 0.094 0.148 0.758 0.143 0.295 0.562 
120 1.48 Br 0.134 0.175 0.691 0.323 0.261 0.415 
741 1.48 Br 0.134 0.175 0.691 0.323 0.261 0.415 
217 1.48 Br 0.207 0.161 0.632 0.467 0.120 0.413 
752 1.49 Br 0.024 0.083 0.892 0.000 0.130 0.870 
692 1.49 Br 0.150 0.140 0.711 0.229 0.150 0.621 
181 1.50 Br 0.063 0.198 0.739 0.000 0.512 0.488 
726 1.50 Br 0.215 0.221 0.564 0.709 0.083 0.208 
232 1.51 Br 0.207 0.161 0.632 0.467 0.120 0.413 
451 1.51 Br 0.040 0.083 0.877 0.000 0.064 0.936 
753 1.53 Br 0.000 0.006 0.994 0.000 0.056 0.944 
825 1.54 Br 0.001 0.026 0.973 0.000 0.426 0.574 
948 1.54 Br 0.134 0.175 0.691 0.323 0.261 0.415 
374 1.55 Br 0.283 0.241 0.476 0.876 0.040 0.084 
695 1.55 Br 0.150 0.140 0.711 0.229 0.150 0.621 
657 1.56 Br 0.375 0.264 0.361 0.376 0.419 0.205 
298 1.57 Br 0.000 0.025 0.975 0.000 0.260 0.740 
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531 1.57 Br 0.063 0.198 0.739 0.000 0.512 0.488 
975 1.58 Br 0.215 0.221 0.564 0.709 0.083 0.208 
273 1.58 Br 0.150 0.140 0.711 0.229 0.150 0.621 
932 1.60 Br 0.229 0.128 0.643 0.325 0.068 0.607 
219 1.60 Br 0.277 0.179 0.543 0.719 0.073 0.208 
492 1.60 Br 0.375 0.264 0.361 0.376 0.419 0.205 
367 1.60 Br 0.094 0.148 0.758 0.143 0.295 0.562 
313 1.61 Br 0.306 0.142 0.552 0.591 0.048 0.361 
916 1.61 Br 0.140 0.241 0.620 0.557 0.206 0.237 
873 1.62 Br 0.150 0.140 0.711 0.229 0.150 0.621 
853 1.62 Br 0.134 0.175 0.691 0.323 0.261 0.415 
396 1.63 Br 0.024 0.083 0.892 0.000 0.130 0.870 
176 1.63 Br 0.024 0.083 0.892 0.000 0.130 0.870 
845 1.64 Br 0.094 0.177 0.729 0.000 0.121 0.879 
124 1.65 Br 0.207 0.161 0.632 0.467 0.120 0.413 
231 1.67 I 0.150 0.140 0.711 0.229 0.150 0.621 
412 1.68 I 0.150 0.140 0.711 0.229 0.150 0.621 
233 1.68 I 0.094 0.148 0.758 0.143 0.295 0.562 
200 1.68 I 0.306 0.142 0.552 0.591 0.048 0.361 
943 1.69 I 0.150 0.140 0.711 0.229 0.150 0.621 
279 1.70 I 0.277 0.179 0.543 0.719 0.073 0.208 
856 1.71 I 0.185 0.201 0.614 0.575 0.183 0.242 
672 1.72 I 0.004 0.090 0.906 0.000 0.863 0.137 
700 1.72 I 0.207 0.161 0.632 0.467 0.120 0.413 
487 1.72 I 0.000 0.006 0.994 0.000 0.056 0.944 
197 1.74 I 0.207 0.161 0.632 0.467 0.120 0.413 
319 1.74 I 0.134 0.175 0.691 0.323 0.261 0.415 
121 1.76 I 0.094 0.148 0.758 0.143 0.295 0.562 
852 1.77 I 0.195 0.330 0.475 0.000 0.492 0.508 
765 1.79 I 0.094 0.148 0.758 0.143 0.295 0.562 
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869 1.81 I 0.299 0.253 0.448 0.182 0.515 0.303 
321 1.82 I 0.150 0.140 0.711 0.229 0.150 0.621 
862 1.85 I 0.253 0.393 0.354 0.349 0.560 0.091 
368 1.85 I 0.094 0.148 0.758 0.143 0.295 0.562 
354 1.87 I 0.299 0.253 0.448 0.182 0.515 0.303 
186 1.89 I 0.375 0.264 0.361 0.376 0.419 0.205 
537 1.91 I 0.277 0.179 0.543 0.719 0.073 0.208 
259 1.91 I 0.207 0.161 0.632 0.467 0.120 0.413 
135 1.95 I 0.207 0.161 0.632 0.467 0.120 0.413 
254 1.96 I 0.215 0.221 0.564 0.709 0.083 0.208 
658 1.96 I 0.263 0.310 0.427 0.189 0.662 0.149 
538 2.00 I 0.185 0.201 0.614 0.575 0.183 0.242 
388 2.01 I 0.375 0.264 0.361 0.376 0.419 0.205 
839 2.06 I 0.375 0.264 0.361 0.376 0.419 0.205 
823 2.09 I 0.215 0.221 0.564 0.709 0.083 0.208 
512 2.10 I 0.202 0.286 0.512 0.081 0.723 0.196 
297 2.10 I 0.190 0.271 0.539 0.779 0.113 0.108 
182 2.12 I 0.780 0.090 0.130 0.105 0.041 0.854 
991 2.18 I 0.277 0.179 0.543 0.719 0.073 0.208 
645 2.19 I 0.040 0.083 0.877 0.000 0.064 0.936 
536 2.23 I 0.277 0.179 0.543 0.719 0.073 0.208 
758 2.23 I 0.150 0.140 0.711 0.229 0.150 0.621 
735 2.24 I 0.283 0.241 0.476 0.876 0.040 0.084 
653 2.26 I 0.870 0.076 0.053 0.999 0.000 0.001 
170 2.26 I 0.306 0.142 0.552 0.591 0.048 0.361 
196 2.28 I 0.229 0.128 0.643 0.325 0.068 0.607 
763 2.30 I 0.094 0.148 0.758 0.143 0.295 0.562 
518 2.31 I 0.150 0.140 0.711 0.229 0.150 0.621 
256 2.31 I 0.229 0.128 0.643 0.325 0.068 0.607 
327 2.33 Bl 0.134 0.175 0.691 0.323 0.261 0.415 
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369 2.33 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
362 2.36 Bl 0.094 0.148 0.758 0.143 0.295 0.562 
968 2.36 Bl 0.870 0.076 0.053 0.999 0.000 0.001 
168 2.37 Bl 0.306 0.142 0.552 0.591 0.048 0.361 
348 2.37 Bl 0.134 0.175 0.691 0.323 0.261 0.415 
917 2.39 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
678 2.41 Bl 0.564 0.259 0.177 0.906 0.058 0.037 
306 2.42 Bl 0.215 0.221 0.564 0.709 0.083 0.208 
951 2.43 Bl 0.306 0.142 0.552 0.591 0.048 0.361 
586 2.46 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
187 2.46 Bl 0.094 0.148 0.758 0.143 0.295 0.562 
724 2.48 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
893 2.48 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
421 2.48 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
133 2.49 Bl 0.317 0.193 0.490 0.807 0.030 0.163 
847 2.49 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
270 2.51 Bl 0.283 0.241 0.476 0.876 0.040 0.084 
123 2.51 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
149 2.52 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
569 2.52 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
275 2.52 Bl 0.185 0.201 0.614 0.575 0.183 0.242 
746 2.52 Bl 0.249 0.296 0.455 0.907 0.052 0.041 
239 2.53 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
723 2.53 Bl 0.927 0.061 0.012 1.000 0.000 0.000 
652 2.53 Bl 0.140 0.241 0.620 0.557 0.206 0.237 
157 2.54 Bl 0.215 0.221 0.564 0.709 0.083 0.208 
879 2.55 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
574 2.55 Bl 0.253 0.393 0.354 0.349 0.560 0.091 
351 2.58 Bl 0.190 0.271 0.539 0.779 0.113 0.108 
579 2.58 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
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749 2.59 Bl 0.400 0.203 0.397 0.925 0.014 0.061 
145 2.61 Bl 0.283 0.241 0.476 0.876 0.040 0.084 
377 2.61 Bl 0.229 0.128 0.643 0.325 0.068 0.607 
857 2.61 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
122 2.61 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
364 2.62 Bl 0.359 0.254 0.387 0.953 0.017 0.030 
234 2.62 Bl 0.375 0.264 0.361 0.376 0.419 0.205 
160 2.62 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
867 2.63 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
539 2.64 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
827 2.64 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
768 2.64 Bl 0.314 0.405 0.281 0.583 0.367 0.050 
268 2.65 Bl 0.283 0.241 0.476 0.876 0.040 0.084 
305 2.66 Bl 0.215 0.221 0.564 0.709 0.083 0.208 
673 2.66 Bl 0.331 0.324 0.345 0.380 0.522 0.098 
278 2.67 Bl 0.503 0.211 0.286 0.579 0.205 0.217 
987 2.68 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
698 2.69 Bl 0.094 0.148 0.758 0.143 0.295 0.562 
453 2.69 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
612 2.70 Bl 0.283 0.241 0.476 0.876 0.040 0.084 
625 2.70 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
834 2.71 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
947 2.71 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
276 2.73 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
457 2.73 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
318 2.74 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
826 2.75 Bl 0.963 0.035 0.003 1.000 0.000 0.000 
128 2.76 Bl 0.899 0.066 0.035 1.000 0.000 0.000 
260 2.77 Bl 0.134 0.175 0.691 0.323 0.261 0.415 
419 2.78 Bl 0.150 0.140 0.711 0.229 0.150 0.621 
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986 2.78 Bl 0.229 0.128 0.643 0.325 0.068 0.607 
165 2.79 Bl 0.134 0.175 0.691 0.323 0.261 0.415 
137 2.80 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
172 2.82 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
134 2.83 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
147 2.84 Bl 0.306 0.142 0.552 0.591 0.048 0.361 
458 2.85 Bl 0.306 0.142 0.552 0.591 0.048 0.361 
285 2.85 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
769 2.90 Bl 0.229 0.128 0.643 0.325 0.068 0.607 
927 2.91 Bl 0.094 0.148 0.758 0.143 0.295 0.562 
945 2.92 Bl 0.283 0.241 0.476 0.876 0.040 0.084 
148 2.95 Bl 0.400 0.203 0.397 0.925 0.014 0.061 
169 2.96 Bl 0.503 0.211 0.286 0.579 0.205 0.217 
936 2.97 Bl 0.185 0.201 0.614 0.575 0.183 0.242 
851 2.99 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
184 2.99 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
152 3.00 Bl 0.207 0.161 0.632 0.467 0.120 0.413 
251 3.02 Bl 0.283 0.241 0.476 0.876 0.040 0.084 
796 3.05 Bl 0.317 0.193 0.490 0.807 0.030 0.163 
132 3.06 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
498 3.10 Bl 0.400 0.203 0.397 0.925 0.014 0.061 
250 3.11 Bl 0.134 0.175 0.691 0.323 0.261 0.415 
728 3.17 Bl 0.277 0.179 0.543 0.719 0.073 0.208 
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Appendix C. BN Prediction Probabilities 
   EQUAL FREQUENCY 
Sample IMI IMI 
Color 
Bl Br Int Bl Br Int 
719 1.25 Br 0.0 94.6 5.4 0.0 97.6 2.4 
264 1.26 Br 12.8 54.8 32.4 17.3 65.7 17.0 
983 1.26 Br 41.6 31.6 26.8 52.0 36.1 12.9 
194 1.27 Br 79.9 7.3 12.8 87.5 7.1 5.4 
283 1.28 Br 0.0 94.6 5.4 0.0 97.6 2.4 
639 1.28 Br 0.0 92.4 7.6 0.0 96.5 3.5 
185 1.30 Br 26.5 42.0 31.5 34.9 49.0 16.1 
193 1.30 Br 96.6 3.4 0.0 97.0 3.0 0.0 
281 1.30 Br 26.5 42.0 31.5 34.9 49.0 16.1 
571 1.32 Br 22.6 46.4 31.0 29.8 54.3 15.8 
930 1.32 Br 22.6 46.4 31.0 29.8 54.3 15.8 
720 1.32 Br 22.6 46.4 31.0 29.8 54.3 15.8 
516 1.33 Br 41.6 31.6 26.8 52.0 36.1 12.9 
202 1.36 Br 0.0 21.9 78.1 0.0 39.1 60.9 
296 1.37 Br 0.0 96.6 3.4 0.0 98.5 1.5 
271 1.38 Br 41.6 31.6 26.8 52.0 36.1 12.9 
812 1.38 Br 0.0 94.6 5.4 0.0 97.6 2.4 
965 1.39 Br 100.0 0.0 0.0 100.0 0.0 0.0 
785 1.39 Br 12.8 54.8 32.4 17.3 65.7 17.0 
957 1.40 Br 0.0 96.1 3.9 0.0 98.3 1.7 
125 1.40 Br 0.0 93.2 6.8 0.0 96.9 3.1 
578 1.40 Br 0.0 96.6 3.4 0.0 98.5 1.5 
163 1.41 Br 26.5 42.0 31.5 34.9 49.0 16.1 
519 1.41 Br 84.1 15.9 0.0 85.6 14.4 0.0 
756 1.41 Br 12.8 54.8 32.4 17.3 65.7 17.0 
161 1.41 Br 0.0 85.5 14.5 0.0 93.1 6.9 
529 1.42 Br 26.5 42.0 31.5 34.9 49.0 16.1 
143 1.43 Br 19.3 7.4 73.3 35.6 12.2 52.2 
742 1.43 Br 41.6 31.6 26.8 52.0 36.1 12.9 
584 1.43 Br 12.8 54.8 32.4 17.3 65.7 17.0 
269 1.44 Br 41.6 31.6 26.8 52.0 36.1 12.9 
528 1.45 Br 41.6 31.6 26.8 52.0 36.1 12.9 
634 1.45 Br 67.3 12.8 19.9 78.0 13.1 8.9 
372 1.45 Br 41.6 31.6 26.8 52.0 36.1 12.9 
751 1.46 Br 12.8 54.8 32.4 17.3 65.7 17.0 
791 1.46 Br 22.6 46.4 31.0 29.8 54.3 15.8 
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328 1.47 Br 41.6 31.6 26.8 52.0 36.1 12.9 
286 1.47 Br 0.0 94.6 5.4 0.0 97.6 2.4 
300 1.47 Br 0.0 94.6 5.4 0.0 97.6 2.4 
378 1.47 Br 0.0 92.4 7.6 0.0 96.5 3.5 
265 1.48 Br 12.8 54.8 32.4 17.3 65.7 17.0 
120 1.48 Br 26.5 42.0 31.5 34.9 49.0 16.1 
741 1.48 Br 26.5 42.0 31.5 34.9 49.0 16.1 
217 1.48 Br 41.6 31.6 26.8 52.0 36.1 12.9 
752 1.49 Br 0.0 94.6 5.4 0.0 97.6 2.4 
692 1.49 Br 22.6 46.4 31.0 29.8 54.3 15.8 
181 1.50 Br 0.0 60.0 40.0 0.0 77.5 22.5 
726 1.50 Br 62.6 16.1 21.3 73.5 16.8 9.7 
232 1.51 Br 41.6 31.6 26.8 52.0 36.1 12.9 
451 1.51 Br 0.0 93.9 6.1 0.0 97.3 2.7 
753 1.53 Br 0.0 85.5 14.5 0.0 93.1 6.9 
825 1.54 Br 0.0 96.6 3.4 0.0 98.5 1.5 
948 1.54 Br 26.5 42.0 31.5 34.9 49.0 16.1 
374 1.55 Br 79.6 7.6 12.7 87.2 7.4 5.4 
695 1.55 Br 22.6 46.4 31.0 29.8 54.3 15.8 
657 1.56 Br 19.3 7.4 73.3 35.6 12.2 52.2 
298 1.57 Br 0.0 93.4 6.6 0.0 97.0 3.0 
531 1.57 Br 0.0 60.0 40.0 0.0 77.5 22.5 
273 1.58 Br 22.6 46.4 31.0 29.8 54.3 15.8 
975 1.58 Br 62.6 16.1 21.3 73.5 16.8 9.7 
932 1.60 Br 84.1 15.9 0.0 85.6 14.4 0.0 
219 1.60 Br 79.9 7.3 12.8 87.5 7.1 5.4 
492 1.60 Br 19.3 7.4 73.3 35.6 12.2 52.2 
367 1.60 Br 12.8 54.8 32.4 17.3 65.7 17.0 
916 1.61 Br 46.2 24.8 29.0 58.2 27.7 14.1 
313 1.61 Br 93.4 6.6 0.0 94.1 5.9 0.0 
873 1.62 Br 22.6 46.4 31.0 29.8 54.3 15.8 
853 1.62 Br 26.5 42.0 31.5 34.9 49.0 16.1 
396 1.63 Br 0.0 94.6 5.4 0.0 97.6 2.4 
176 1.63 Br 0.0 94.6 5.4 0.0 97.6 2.4 
845 1.64 Br 0.0 86.0 14.0 0.0 93.4 6.6 
124 1.65 Br 41.6 31.6 26.8 52.0 36.1 12.9 
231 1.67 I 22.6 46.4 31.0 29.8 54.3 15.8 
233 1.68 I 12.8 54.8 32.4 17.3 65.7 17.0 
412 1.68 I 22.6 46.4 31.0 29.8 54.3 15.8 
200 1.68 I 93.4 6.6 0.0 94.1 5.9 0.0 
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943 1.69 I 22.6 46.4 31.0 29.8 54.3 15.8 
279 1.70 I 79.9 7.3 12.8 87.5 7.1 5.4 
856 1.71 I 67.3 12.8 19.9 78.0 13.1 8.9 
672 1.72 I 0.0 15.6 84.4 0.0 29.7 70.3 
700 1.72 I 26.5 42.0 31.5 34.9 49.0 16.1 
487 1.72 I 0.0 85.5 14.5 0.0 93.1 6.9 
197 1.74 I 41.6 31.6 26.8 52.0 36.1 12.9 
319 1.74 I 26.5 42.0 31.5 34.9 49.0 16.1 
121 1.76 I 12.8 54.8 32.4 17.3 65.7 17.0 
852 1.77 I 0.0 34.6 65.4 0.0 54.9 45.1 
765 1.79 I 12.8 54.8 32.4 17.3 65.7 17.0 
869 1.81 I 9.9 10.3 79.8 19.8 18.3 61.9 
321 1.82 I 22.6 46.4 31.0 29.8 54.3 15.8 
862 1.85 I 20.1 5.5 74.4 37.5 9.0 53.5 
368 1.85 I 12.8 54.8 32.4 17.3 65.7 17.0 
354 1.87 I 9.9 10.3 79.8 19.8 18.3 61.9 
186 1.89 I 19.3 7.4 73.3 35.6 12.2 52.2 
259 1.91 I 41.6 31.6 26.8 52.0 36.1 12.9 
537 1.91 I 79.9 7.3 12.8 87.5 7.1 5.4 
135 1.95 I 41.6 31.6 26.8 52.0 36.1 12.9 
254 1.96 I 62.6 16.1 21.3 73.5 16.8 9.7 
658 1.96 I 11.4 9.1 79.5 22.6 16.1 61.3 
538 2.00 I 67.3 12.8 19.9 78.0 13.1 8.9 
388 2.01 I 19.3 7.4 73.3 35.6 12.2 52.2 
839 2.06 I 19.3 7.4 73.3 35.6 12.2 52.2 
823 2.09 I 62.6 16.1 21.3 73.5 16.8 9.7 
512 2.10 I 5.5 12.0 82.5 11.5 22.1 66.4 
297 2.10 I 66.9 13.3 19.8 77.5 13.7 8.8 
182 2.12 I  --  --  -- 100.0 0.0 0.0 
991 2.18 I 79.9 7.3 12.8 87.5 7.1 5.4 
645 2.19 I 0.0 93.9 6.1 0.0 97.3 2.7 
536 2.23 I 79.9 7.3 12.8 87.5 7.1 5.4 
758 2.23 I 22.6 46.4 31.0 29.8 54.3 15.8 
735 2.24 I 79.6 7.6 12.7 87.2 7.4 5.4 
653 2.26 I 100.0 0.0 0.0 100.0 0.0 0.0 
170 2.26 I 93.4 5.6 0.0 94.1 5.9 0.0 
196 2.28 I 84.1 15.9 0.0 85.6 14.4 0.0 
763 2.30 I 12.8 54.8 32.4 17.3 65.7 17.0 
256 2.31 I 84.1 15.9 0.0 85.6 14.4 0.0 
518 2.31 I 22.6 46.4 31.0 29.8 54.3 15.8 
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327 2.33 Bl 26.5 42.0 31.5 34.9 49.0 16.1 
369 2.33 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
362 2.36 Bl 12.8 54.8 32.4 17.3 65.7 17.0 
968 2.36 Bl 100.0 0.0 0.0 100.0 0.0 0.0 
168 2.37 Bl 93.4 6.6 0.0 94.1 5.9 0.0 
348 2.37 Bl 26.5 42.0 31.5 34.9 49.0 16.1 
917 2.39 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
678 2.41 Bl 99.6 0.4 0.0 99.6 0.4 0.0 
306 2.42 Bl 62.6 16.1 21.3 73.5 16.8 9.7 
951 2.43 Bl 93.4 6.6 0.0 94.1 5.9 0.0 
187 2.46 Bl 12.8 54.8 32.4 17.3 65.7 17.0 
586 2.46 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
724 2.48 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
893 2.48 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
421 2.48 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
133 2.49 Bl 97.7 2.3 0.0 97.9 2.1 0.0 
847 2.49 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
270 2.51 Bl 79.6 7.6 12.7 87.2 7.4 5.4 
123 2.51 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
149 2.52 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
275 2.52 Bl 67.3 12.8 19.9 78.0 13.1 8.9 
569 2.52 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
746 2.52 Bl 91.1 2.2 6.7 95.3 2.0 2.7 
239 2.53 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
723 2.53 Bl 100.0 0.0 0.0 100.0 0.0 0.0 
652 2.53 Bl 46.2 24.8 29.0 58.2 27.7 14.1 
157 2.54 Bl 62.6 16.1 21.3 73.5 16.8 9.7 
879 2.55 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
574 2.55 Bl 20.1 5.5 74.4 37.5 9.0 53.5 
579 2.58 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
351 2.58 Bl 66.9 13.3 19.8 77.5 13.7 8.8 
749 2.59 Bl 99.1 0.9 0.0 99.2 0.8 0.0 
145 2.61 Bl 79.6 7.6 12.7 87.2 7.4 5.4 
377 2.61 Bl 84.1 15.9 0.0 85.6 14.4 0.0 
857 2.61 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
122 2.61 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
364 2.62 Bl 95.1 1.1 3.8 97.5 1.0 1.5 
234 2.62 Bl 19.3 7.4 73.3 35.6 12.2 52.2 
160 2.62 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
867 2.63 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
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539 2.64 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
827 2.64 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
768 2.64 Bl 35.2 3.5 61.2 56.8 5.1 38.1 
268 2.65 Bl 79.6 7.6 12.7 87.2 7.4 5.4 
305 2.66 Bl 62.6 16.1 21.3 73.5 16.8 9.7 
673 2.66 Bl 35.2 3.4 61.4 56.8 4.8 38.3 
278 2.67 Bl 96.6 3.4 0.0 97.0 3.0 0.0 
987 2.68 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
698 2.69 Bl 12.8 54.8 32.4 17.3 65.7 17.0 
453 2.69 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
612 2.70 Bl 79.6 7.6 12.7 87.2 7.4 5.4 
625 2.70 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
947 2.71 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
834 2.71 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
276 2.73 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
457 2.73 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
318 2.74 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
826 2.75 Bl 100.0 0.0 0.0 100.0 0.0 0.0 
128 2.76 Bl 100.0 0.0 0.0 100.0 0.0 0.0 
260 2.77 Bl 26.5 42.0 31.5 34.9 49.0 16.1 
419 2.78 Bl 22.6 46.4 31.0 29.8 54.3 15.8 
986 2.78 Bl 84.1 15.9 0.0 85.6 14.4 0.0 
165 2.79 Bl 26.5 42.0 31.5 34.9 49.0 16.1 
137 2.80 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
172 2.82 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
134 2.83 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
147 2.84 Bl 93.4 6.6 0.0 94.1 5.9 0.0 
285 2.85 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
458 2.85 Bl 93.4 6.6 0.0 94.1 5.9 0.0 
769 2.90 Bl 84.1 15.9 0.0 85.6 14.4 0.0 
927 2.91 Bl 12.8 54.8 32.4 17.3 65.7 17.0 
945 2.92 Bl 79.6 7.6 12.7 87.2 7.4 5.4 
148 2.95 Bl 99.1 0.9 0.0 99.2 0.8 0.0 
169 2.96 Bl 96.6 3.4 0.0 97.0 3.0 0.0 
936 2.97 Bl 67.3 12.8 19.9 78.0 13.1 8.9 
184 2.99 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
851 2.99 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
152 3.00 Bl 41.6 31.6 26.8 52.0 36.1 12.9 
251 3.02 Bl 79.6 7.6 12.7 87.2 7.4 5.4 
796 3.05 Bl 97.7 2.3 0.0 97.9 2.1 0.0 
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132 3.06 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
498 3.10 Bl 99.1 0.9 0.0 99.2 0.8 0.0 
250 3.11 Bl 26.5 42.0 31.5 34.9 49.0 16.1 
728 3.17 Bl 79.9 7.3 12.8 87.5 7.1 5.4 
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Appendix D. BN Likelihood Ratios 
     Equal Odds Adjusted Odds 
Sample IMI IMI Color Bl Br Int Bl Br Int 
719 1.25 Br 0.0 35.0 0.1 0.0 63.6 0.1 
264 1.26 Br 0.3 2.4 1.0 0.3 3.0 1.0 
983 1.26 Br 1.4 0.9 0.7 1.4 0.9 0.7 
194 1.27 Br 8.0 0.2 0.3 8.9 0.1 0.3 
283 1.28 Br 0.0 35.0 0.1 0.0 63.6 0.1 
639 1.28 Br 0.0 24.3 0.2 0.0 43.1 0.2 
185 1.30 Br 0.7 1.4 0.9 0.7 1.5 0.9 
281 1.30 Br 0.7 1.4 0.9 0.7 1.5 0.9 
193 1.30 Br 56.8 0.1 0.0 41.2 0.0 0.0 
571 1.32 Br 0.6 1.7 0.9 0.5 1.9 0.9 
930 1.32 Br 0.6 1.7 0.9 0.5 1.9 0.9 
720 1.32 Br 0.6 1.7 0.9 0.5 1.9 0.9 
516 1.33 Br 1.4 0.9 0.7 1.4 0.9 0.7 
202 1.36 Br 0.0 0.6 7.1 0.0 1.0 7.6 
296 1.37 Br 0.0 56.8 0.1 0.0 102.7 0.1 
271 1.38 Br 1.4 0.9 0.7 1.4 0.9 0.7 
812 1.38 Br 0.0 35.0 0.1 0.0 63.6 0.1 
965 1.39 Br  -- 0.0 0.0  -- 0.0 0.0 
785 1.39 Br 0.3 2.4 1.0 0.3 3.0 1.0 
957 1.40 Br 0.0 49.3 0.1 0.0 90.4 0.1 
125 1.40 Br 0.0 27.4 0.6 0.0 48.9 0.2 
578 1.40 Br 0.0 56.8 0.1 0.0 102.7 0.1 
163 1.41 Br 0.7 1.4 0.9 0.7 1.5 0.9 
519 1.41 Br 10.6 0.4 0.0 7.6 0.3 0.0 
756 1.41 Br 0.3 2.4 1.0 0.3 3.0 1.0 
161 1.41 Br 0.0 11.8 0.3 0.0 21.1 0.4 
529 1.42 Br 0.7 1.4 0.9 0.7 1.5 0.9 
742 1.43 Br 1.4 0.9 0.7 1.4 0.9 0.7 
143 1.43 Br 0.5 0.2 5.5 0.7 0.2 5.3 
584 1.43 Br 0.3 2.4 1.0 0.3 3.0 1.0 
269 1.44 Br 1.4 0.9 0.7 1.4 0.9 0.7 
634 1.45 Br 4.1 0.3 0.5 4.5 0.2 0.5 
528 1.45 Br 1.4 0.9 0.7 1.4 0.9 0.7 
372 1.45 Br 1.4 0.9 0.7 1.4 0.9 0.7 
751 1.46 Br 0.3 2.4 1.0 0.3 3.0 1.0 
791 1.46 Br 0.6 1.7 0.9 0.5 1.9 0.9 
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328 1.47 Br 1.4 0.9 0.7 1.4 0.9 0.7 
286 1.47 Br 0.0 35.0 0.1 0.0 63.6 0.1 
300 1.47 Br 0.0 35.0 0.1 0.0 63.6 0.1 
378 1.47 Br 0.0 24.3 0.2 0.0 43.1 0.2 
265 1.48 Br 0.3 2.4 1.0 0.3 3.0 1.0 
120 1.48 Br 0.7 1.4 0.9 0.7 1.5 0.9 
741 1.48 Br 0.7 1.4 0.9 0.7 1.5 0.9 
217 1.48 Br 1.4 0.9 0.7 1.4 0.9 0.7 
752 1.49 Br 0.0 35.0 0.1 0.0 63.6 0.1 
692 1.49 Br 0.6 1.7 0.9 0.5 1.9 0.9 
181 1.50 Br 0.0 3.0 1.3 0.0 5.4 1.4 
726 1.50 Br 3.3 0.4 0.5 3.5 0.3 0.5 
232 1.51 Br 1.4 0.9 0.7 1.4 0.9 0.7 
451 1.51 Br 0.0 30.8 0.4 0.0 56.4 0.1 
753 1.53 Br 0.0 11.8 0.3 0.0 21.1 0.4 
825 1.54 Br 0.0 56.8 0.1 0.0 102.7 0.1 
948 1.54 Br 0.7 1.4 0.9 0.7 1.5 0.9 
374 1.55 Br 7.8 0.2 0.3 8.7 0.1 0.3 
695 1.55 Br 0.6 1.7 0.9 0.5 1.9 0.9 
657 1.56 Br 0.5 0.2 5.5 0.7 0.2 5.3 
531 1.57 Br 0.0 3.0 1.3 0.0 5.4 1.4 
298 1.57 Br 0.0 28.3 0.1 0.0 50.6 0.2 
975 1.58 Br 3.3 0.4 0.5 3.5 0.3 0.5 
273 1.58 Br 0.6 1.7 0.9 0.5 1.9 0.9 
932 1.60 Br 10.6 0.4 0.0 7.6 0.3 0.0 
219 1.60 Br 8.0 0.2 0.3 8.9 0.1 0.3 
492 1.60 Br 0.5 0.2 5.5 0.7 0.2 5.3 
367 1.60 Br 0.3 2.4 1.0 0.3 3.0 1.0 
916 1.61 Br 1.7 0.7 0.8 1.8 0.6 0.8 
313 1.61 Br 28.3 0.1 0.0 20.3 0.1 0.0 
873 1.62 Br 0.6 1.7 0.9 0.5 1.9 0.9 
853 1.62 Br 0.7 1.4 0.9 0.7 1.5 0.9 
396 1.63 Br 0.0 35.0 0.1 0.0 63.6 0.1 
176 1.63 Br 0.0 35.0 0.1 0.0 63.6 0.1 
845 1.64 Br 0.0 12.3 0.3 0.0 22.1 0.3 
124 1.65 Br 1.4 0.9 0.7 1.4 0.9 0.7 
231 1.67 I 0.6 1.7 0.9 0.5 1.9 0.9 
233 1.68 I 0.3 2.4 1.0 0.3 3.0 1.0 
412 1.68 I 0.6 1.7 0.9 0.5 1.9 0.9 
200 1.68 I 28.3 0.1 0.0 20.3 0.1 0.0 
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943 1.69 I 0.6 1.7 0.9 0.5 1.9 0.9 
279 1.70 I 8.0 0.2 0.3 8.9 0.1 0.3 
856 1.71 I 4.1 0.3 0.5 4.5 0.2 0.5 
672 1.72 I 0.0 0.4 10.8 0.0 0.7 11.6 
700 1.72 I 0.7 1.4 0.9 0.7 1.5 0.9 
487 1.72 I 0.0 11.8 0.3 0.0 21.1 0.4 
197 1.74 I 1.4 0.9 0.7 1.4 0.9 0.7 
319 1.74 I 0.7 1.4 0.9 0.7 1.5 0.9 
121 1.76 I 0.3 2.4 1.0 0.3 3.0 1.0 
852 1.77 I 0.0 1.1 3.8 0.0 1.9 4.0 
765 1.79 I 0.3 2.4 1.0 0.3 3.0 1.0 
869 1.81 I 0.2 0.2 7.9 0.3 0.4 7.9 
321 1.82 I 0.6 1.7 0.9 0.5 1.9 0.9 
862 1.85 I 0.5 0.1 5.8 0.8 0.2 5.6 
368 1.85 I 0.3 2.4 1.0 0.3 3.0 1.0 
354 1.87 I 0.2 0.2 7.9 0.3 0.4 7.9 
186 1.89 I 0.5 0.2 5.5 0.7 0.2 5.3 
259 1.91 I 1.4 0.9 0.7 1.4 0.9 0.7 
537 1.91 I 8.0 0.2 0.3 8.9 0.1 0.3 
135 1.95 I 1.4 0.9 0.7 1.4 0.9 0.7 
254 1.96 I 3.3 0.4 0.5 3.5 0.3 0.5 
658 1.96 I 0.3 0.2 7.8 0.4 0.3 7.7 
538 2.00 I 4.1 0.3 0.5 4.5 0.2 0.5 
388 2.01 I 0.5 0.2 5.5 0.7 0.2 5.3 
839 2.06 I 0.5 0.2 5.5 0.7 0.2 5.3 
823 2.09 I 3.3 0.4 0.5 3.5 0.3 0.5 
512 2.10 I 0.1 0.3 9.4 0.2 0.4 9.6 
297 2.10 I 4.0 0.3 0.5 4.4 0.2 0.5 
182 2.12 I  -- 0.0 0.0  -- 0.0 0.0 
991 2.18 I 8.0 0.2 0.3 8.9 0.1 0.3 
645 2.19 I 0.0 30.8 0.4 0.0 56.4 0.1 
536 2.23 I 8.0 0.2 0.3 8.9 0.1 0.3 
758 2.23 I 0.6 1.7 0.9 0.5 1.9 0.9 
735 2.24 I 7.8 0.2 0.3 8.7 0.1 0.3 
653 2.26 I  -- 0.0 0.0  -- 0.0 0.0 
170 2.26 I 28.3 0.1 0.0 20.4 0.1 0.0 
196 2.28 I 10.6 0.4 0.0 7.6 0.3 0.0 
763 2.30 I 0.3 2.4 1.0 0.3 3.0 1.0 
518 2.31 I 0.6 1.7 0.9 0.5 1.9 0.9 
256 2.31 I 10.6 0.4 0.0 7.6 0.3 0.0 
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327 2.33 Bl 0.7 1.4 0.9 0.7 1.5 0.9 
369 2.33 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
362 2.36 Bl 0.3 2.4 1.0 0.3 3.0 1.0 
968 2.36 Bl  -- 0.0 0.0  -- 0.0 0.0 
168 2.37 Bl 28.3 0.1 0.0 20.3 0.1 0.0 
348 2.37 Bl 0.7 1.4 0.9 0.7 1.5 0.9 
917 2.39 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
678 2.41 Bl 498.0 0.01 0.0 316.9 0.0 0.0 
306 2.42 Bl 3.3 0.4 0.5 3.5 0.3 0.5 
951 2.43 Bl 28.3 0.1 0.0 20.3 0.1 0.0 
187 2.46 Bl 0.3 2.4 1.0 0.3 3.0 1.0 
586 2.46 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
724 2.48 I 1.4 0.9 0.7 1.4 0.9 0.7 
893 2.48 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
421 2.48 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
133 2.49 Bl 85.0 0.05 0.0 59.3 0.0 0.0 
847 2.49 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
270 2.51 Bl 7.8 0.2 0.3 8.7 0.1 0.3 
123 2.51 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
275 2.52 Bl 4.1 0.3 0.5 4.5 0.2 0.5 
149 2.52 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
569 2.52 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
746 2.52 Bl 20.5 0.0 0.1 25.8 0.0 0.1 
239 2.53 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
723 2.53 Bl  -- 0.0 0.0  -- 0.0 0.0 
652 2.53 Bl 1.7 0.7 0.8 1.8 0.6 0.8 
157 2.54 Bl 3.3 0.4 0.5 3.5 0.3 0.5 
879 2.55 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
574 2.55 Bl 0.5 0.1 5.8 0.8 0.2 5.6 
579 2.58 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
351 2.58 Bl 4.0 0.3 0.5 4.4 0.2 0.5 
749 2.59 Bl 220.2 0.02 0.0 157.8 0.0 0.0 
145 2.61 Bl 7.8 0.2 0.3 8.7 0.1 0.3 
377 2.61 Bl 10.6 0.4 0.0 7.6 0.3 0.0 
857 2.61 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
122 2.61 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
364 2.62 Bl 38.8 0.0 0.1 49.6 0.0 0.1 
234 2.62 Bl 0.5 0.2 5.5 0.7 0.2 5.3 
160 2.62 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
867 2.63 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
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539 2.64 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
827 2.64 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
768 2.64 Bl 1.1 0.1 3.2 1.7 0.1 3.0 
268 2.65 Bl 7.8 0.2 0.3 8.7 0.1 0.3 
305 2.66 Bl 3.3 0.4 0.5 3.5 0.3 0.5 
673 2.66 Bl 1.1 0.1 3.2 1.7 0.1 3.0 
278 2.67 Bl 56.8 0.1 0.0 41.2 0.0 0.0 
987 2.68 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
698 2.69 Bl 0.3 2.4 1.0 0.3 3.0 1.0 
453 2.69 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
625 2.70 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
612 2.70 Bl 7.8 0.2 0.3 8.7 0.1 0.3 
947 2.71 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
834 2.71 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
457 2.73 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
276 2.73 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
318 2.74 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
826 2.75 Bl  -- 0.0 0.0  -- 0.0 0.0 
128 2.76 Bl  -- 0.0 0.0  -- 0.0 0.0 
260 2.77 Bl 0.7 1.4 0.9 0.7 1.5 0.9 
419 2.78 Bl 0.6 1.7 0.9 0.5 1.9 0.9 
986 2.78 Bl 10.6 0.4 0.0 7.6 0.3 0.0 
165 2.79 Bl 0.7 1.4 0.9 0.7 1.5 0.9 
137 2.80 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
172 2.82 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
134 2.83 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
147 2.84 Bl 28.3 0.1 0.0 20.3 0.1 0.0 
285 2.85 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
458 2.85 Bl 28.3 0.1 0.0 20.3 0.1 0.0 
769 2.90 Bl 10.6 0.4 0.0 7.6 0.3 0.0 
927 2.91 Bl 0.3 2.4 1.0 0.3 3.0 1.0 
945 2.92 Bl 7.8 0.2 0.3 8.7 0.1 0.3 
148 2.95 Bl 220.2 0.02 0.0 157.8 0.0 0.0 
169 2.96 Bl 56.8 0.1 0.0 41.2 0.0 0.0 
936 2.97 Bl 4.1 0.3 0.5 4.5 0.2 0.5 
184 2.99 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
851 2.99 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
152 3.00 Bl 1.4 0.9 0.7 1.4 0.9 0.7 
251 3.02 Bl 7.8 0.2 0.3 8.7 0.1 0.3 
796 3.05 Bl 85.0 0.05 0.0 59.3 0.0 0.0 
83 
 
132 3.06 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
498 3.10 Bl 220.2 0.02 0.0 157.8 0.0 0.0 
250 3.11 Bl 0.7 1.4 0.9 0.7 1.5 0.9 
728 3.17 Bl 8.0 0.2 0.3 8.9 0.1 0.3 
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Appendix E. Digital Photo Collection 
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Appendix F. SNP Profile Electropherograms 
 
Figure F1. Sample 120 
Figure F2. Sample 121
Figure F3. Sample 122
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Figure F4. Sample 123
Figure F5. Sample 124
Figure F6. Sample 125
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Figure F7. Sample 128
Figure F8. Sample 132
Figure F9. Sample 133
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Figure F10. Sample 134
Figure F11. Sample 135
Figure F12. Sample 137
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Figure F13. Sample 143
Figure F14. Sample 145
Figure F15. Sample 147
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Figure F16. Sample 148
Figure F17. Sample 149
Figure F18. Sample 152
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Figure F19. Sample 157
Figure F20. Sample 160
Figure F21. Sample 161
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Figure F22. Sample 163
Figure F23. Sample 165
Figure F24. Sample 168
99 
 
Figure F25. Sample 169
Figure F26. Sample 170
Figure F27. Sample 172
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Figure F28. Sample 176
Figure F29. Sample 181 
Figure F30. Sample 182
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Figure F31. Sample 184
Figure F32. Sample 185
Figure F33. Sample 186
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Figure F34. Sample 187
Figure F35. Sample 193
Figure F36. Sample 194
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Figure F37. Sample 196
Figure F38. Sample 197
Figure F39. Sample 200
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Figure F40. Sample 202
Figure F41. Sample 217
Figure F42. Sample 219
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Figure F43. Sample 231
Figure F44. Sample 232
Figure F45. Sample 233
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Figure F46. Sample 234
Figure F47. Sample 239
Figure F48. Sample 250
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Figure F49. Sample 251
Figure F50. Sample 254
Figure F51. Sample 256
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Figure F52. Sample 259
Figure F53. Sample 260
Figure F54. Sample 264
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Figure F55. Sample 265
Figure F56. Sample 268
Figure F57. Sample 269
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Figure F58. Sample 270
Figure F59. Sample 271
Figure F60. Sample 273
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Figure F61. Sample 275
Figure F62. Sample 276
Figure F63. Sample 278
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Figure F64. Sample 279
Figure F65. Sample 281
Figure F66. Sample 283
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Figure F67. Sample 285
Figure F68. Sample 286
Figure F69. Sample 296
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Figure F70. Sample 297
Figure F71. Sample 298
Figure F72. Sample 300
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Figure F73. Sample 305
Figure F74. Sample 306
Figure F75. Sample 313
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Figure F76. Sample 318
Figure F77. Sample 319
Figure F78. Sample 321
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Figure F79. Sample 327
Figure F80. Sample 328
Figure F81. Sample 348
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Figure F82. Sample 351
Figure F83. Sample 354
Figure F84. Sample 362
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Figure F85. Sample 364
Figure F86. Sample 367
Figure F87. Sample 368
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Figure F88. Sample 369
 
Figure F89. Sample 372
 
Figure F90. Sample 374
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Figure F91. Sample 377
Figure F92. Sample 378
Figure F93. Sample 388
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Figure F94. Sample 396
Figure F95. Sample 412
Figure F96. Sample 419
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Figure F97. Sample 421
Figure F98. Sample 451
Figure F99. Sample 453
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Figure F100. Sample 457
Figure F101. Sample 458
Figure F102. Sample 487
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Figure F103. Sample 492
Figure F104. Sample 498
Figure F105. Sample 512
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Figure F106. Sample 516
Figure F107. Sample 518
Figure F108. Sample 519
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Figure F109. Sample 528
Figure F110. Sample 529
Figure F111. Sample 531
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Figure F112. Sample 536
Figure F113. Sample 537
Figure F114. Sample 538
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Figure F115. Sample 539
Figure F116. Sample 569
Figure F117. Sample 571
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Figure F118. Sample 574
Figure F119. Sample 578
Figure F120. Sample 579
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Figure F121. Sample 584
Figure F122. Sample 586
Figure F123. Sample 612
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Figure F124. Sample 625
Figure F125. Sample 634
Figure F126. Sample 639
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Figure F127. Sample 645
Figure F128. Sample 652
Figure F129. Sample 653
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Figure F130. Sample 657
Figure F131. Sample 658
Figure F132. Sample 672
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Figure F133. Sample 673
Figure F134. Sample 678
Figure F135. Sample 692
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Figure F136. Sample 695
Figure F137. Sample 698
Figure F138. Sample 700
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Figure F139. Sample 719
Figure F140. Sample 720
Figure F141. Sample 723
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Figure F142. Sample 724
Figure F143. Sample 726
Figure F144. Sample 728
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Figure F145. Sample 735
Figure F146. Sample 741
Figure F147. Sample 742
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Figure F148. Sample 746
Figure F149. Sample 749
Figure F150. Sample 751
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Figure F151. Sample 752
Figure F152. Sample 753
Figure F153. Sample 756
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Figure F154. Sample 758
Figure F155. Sample 763
Figure F156. Sample 765
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Figure F157. Sample 768
Figure F158. Sample 769
Figure F159. Sample 785
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Figure F160. Sample 791
Figure F161. Sample 796
Figure F162. Sample 812
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Figure F163. Sample 823
Figure F164. Sample 825
Figure F165. Sample 826
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Figure F166. Sample 827
Figure F167. Sample 834
Figure F168. Sample 839
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Figure F169. Sample 845
Figure F170. Sample 847
Figure F171. Sample 851
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Figure F172. Sample 852
Figure F173. Sample 853
Figure F174. Sample 856
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Figure F175. Sample 857
Figure F176. Sample 862
Figure F177. Sample 867
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Figure F178. Sample 869
Figure F179. Sample 873
Figure F180. Sample 879
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Figure F181. Sample 893
Figure F182. Sample 916
Figure F183. Sample 917
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Figure F184. Sample 927
Figure F185. Sample 930
Figure F186. Sample 932
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Figure F187. Sample 936
Figure F188. Sample 943
Figure F189. Sample 945
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Figure F190. Sample 947
Figure F191. Sample 948
Figure F192. Sample 951
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Figure F193. Sample 957
Figure F194. Sample 965
Figure F195. Sample 968
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Figure F196. Sample 975
Figure F197. Sample 983
Figure F198. Sample 986
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Figure F199. Sample 987
Figure F200. Sample 991 
 
